Minimally invasive enteroscopically guided small bowel resection

DOI: 10.12809/hkmj144270
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
CASE REPORT
Minimally invasive enteroscopically guided small bowel resection
Tommy CH Man, MB, BS; KC Ng, MB, BS; KW Wong, MB, BS; Francis PT Mok, MB, BS
Department of Surgery, Caritas Medical Centre, Shamshuipo, Hong Kong
Corresponding author: Dr Tommy CH Man (manchunhin@gmail.com)
 
 Full paper in PDF
Abstract
Localisation of small bowel pathology is often difficult, especially intramural small bowel lesions. Even with the use of laparoscopy, visualisation of small bowel lesion is not always possible. The most accurate method to identify such a lesion is by laparotomy with direct visualisation and palpation of the lesion. However, the recent trend in surgical development aims for minimally invasive procedures while keeping the excision of surgical pathology safe and complete, with less surgical trauma. This report illustrates a case of minimally invasive enteroscopically guided small bowel resection.
 
 
 
Case report
A 64-year-old male with a history of hepatic carcinosarcoma had his right hemihepatectomy done in 2011. The resection margins were clear and interval computed tomography (CT) scans did not reveal any recurrence.
 
One year after the surgery he was admitted for complaints of non-specific abdominal pain, melena, and dizziness. On admission, the haemoglobin level was only 50 g/L although his oesophagogastroduodenoscopy and colonoscopy were normal. Capsule endoscopy was performed and this showed a fungating tumour in the jejunum with evidence of bleeding. Another CT scan was arranged which confirmed that there was a 2.5-cm intraluminal lesion in the small bowel, suggesting a probable occurrence of gastro-intestinal stromal tumour.
 
Subsequently, single-port laparoscopic resection of the small bowel tumour under single-balloon enteroscopic guidance was performed. The patient was operated on under general anaesthesia in supine position with prophylactic antibiotics. The single-balloon enteroscope (Olympus SIF-Q260; Olympus Medical Systems Corp, Japan) was used to locate the site of tumour (Fig 1a). The lesion was marked with endomarker (Fig 1b) and lipiodol injection, and the enteroscope was left in situ in order to guide the site of skin incision. Fluoroscopy and transillumination of the small bowel at the site of lesion confirmed that the tumour was situated in the left upper quadrant of the abdomen (Figs 2a and 2b).
 

Figure 1. Tumour at proximal jejunum (a) before and (b) after endomarker injection
 

Figure 2. (a) Fluoroscopy scan and (b) transillumination of tumour. (c) Retrieval of small bowel and (d) length of incision
 
A 2-cm incision was made for laparoscopic procedure using a Hassan laparoscopic port that was inserted with an 8-degree laparoscope with working channel (OLYMPUS A5252A laparoscope; Olympus Medical Systems Corp, Germany). Laparoscopy procedure confirmed that there were no suspicious hepatic and peritoneal nodules. The diseased part of the small bowel was taken out using a grasper through the working channel after extension of the skin wound (Fig 2c). Usual small bowel resection was done with primary anastomosis using linear staplers and the entire procedure lasted for about 225 minutes.
 
The patient tolerated the whole procedure well and his recovery was satisfactory. He gradually resumed oral feeding and was fit for discharge on day 3 after the procedure.
 
Discussion
Midline laparotomy incision is often a straightforward procedure for treatment and resection of small bowel lesions. The long laparotomy wound, however, may cause a lot of pain, leading to prolonged hospital stay and more analgesic requirement that may impair respiratory function especially in patients with advanced age and multiple co-morbidities.
 
Although capsule endoscopy for identification of small bowel pathologies1 2 has become prevalent in patients with occult gastro-intestinal bleeding, sometimes it renders the operation difficult to accurately determine the site of lesion and locate the tumour.
 
The recent advances in surgical technology and development of new techniques have made minimally invasive procedures possible, like robotic surgery and endoscopic resection. However, the installation of these surgical instruments takes up a lot of space in the operating theatre and increases the cost of enhancement, not to mention the huge maintenance cost.3 4 As such, we present a case of minimally invasive small bowel resection which is cost-effective to be adopted by most hospitals.
 
To recap, the aim of minimally invasive surgery is to reduce surgical morbidity with smaller and less wound while maintaining pathological clearance and safety. In our design, the use of enteroscope provided accurate localisation of the pathology by direct visualisation.5 After confirming the position of the pathology, the skin incision could be precisely made on top of the lesion. Before excising the lesion, laparoscopy was also performed to make sure that there was no intra-abdominal metastatic deposit. The wound was extended to 4.5 cm and this allowed the diseased small bowel to be retrieved for resection as in an open procedure (Fig 2d). The instruments used are readily available in most hospitals and the procedure can be performed at a relatively lower cost.
 
Single-balloon enteroscope, the procedure used in our case, is a recently developed technology for diagnosing small bowel pathology. The setup of this safe enteroscope is simple.6 Moreover, some evidence bore out that the learning curve of single-balloon enteroscope is insignificant.7 8 Previous study also showed that single-balloon enteroscope provided a diagnostic yield similar to double-balloon enteroscope which requires more technical skills.9
 
In this operation, three types of localisation methods were adopted after position of the tumour was confirmed by enteroscopy. These included lipiodol injection, transillumination to localise the incision site, and endomarker injection to find out precisely where the tumour was located.
 
Lipiodol injection at the site of tumour allows localisation of lesion under fluoroscopic guidance, which is useful to guide the site for skin incision. It can be done before operation, hence saves time during intra-operative enteroscopy. The exact position of the tumour, however, may not be easily located by laparoscope after identification of the incision site.
 
In such situations, injection of endomarker before operation is recommended during laparoscopy as this enables better visualisation of the portion of the diseased bowel to be retrieved for further resection. However, endomarker cannot replace lipiodol in localisation of lesion as it is not radio-opaque and cannot aid localisation of skin incision site.
 
Alternatively, transillumination using enteroscope allows real-time localisation of the incision site and this is superior to merely injecting lipiodol. However, the risk of complications arising from intra-operative enteroscope may be hiked up and the operating time may be extended.
 
To facilitate the operation and shorten the time required, preoperative enteroscopy rather than intra-operative enteroscopy should be employed. The injection of lipiodol and endomarker can be done before operation. As an initial attempt of our de-novo technique in this case, we decided to use intra-operative enteroscopy with transillumination for real-time tumour localisation even though the operating time was inevitably prolonged.
 
In addition to the above methods, the use of endoclip is considered a possible option for accurate localisation. Since endoclip is radio-opaque, it can serve both purposes for incision site and tumour localisation under fluoroscopic guidance. Nevertheless, the accuracy could be affected due to the risk of dislodgement of these endoclips.
 
Conclusion
Enteroscope is a safe option for guiding minimally invasive small bowel resection with accurate localisation of pathology. There are different ways for localisation including the use of endomarker, lipiodol injection, transillumination as well as endoclip. Large-scale studies using these techniques should be considered in order to understand the efficacy of such newer methods.
 
References
1. Mavrogenis G, Coumaros D, Bellocq JP, Leroy J. Detection of a polypoid lesion inside a Meckel’s diverticulum using wireless capsule endoscopy. Endoscopy 2011;43 Suppl 2 UCTN:E115-6.
2. Mavrogenis G, Coumaros D, Lakhrib N, Renard C, Bellocq JP, Leroy J. Mixed cavernous hemangioma-lymphangioma of the jejunum: detection by wireless capsule endoscopy. Endoscopy 2011;43 Suppl 2 UCTN:E217-8.
3. Amodeo A, Linares Quevedo A, Joseph JV, Belgrano E, Patel HR. Robotic laparoscopic surgery: cost and training. Minerva Urol Nefrol 2009;61:121-8.
4. Kim CW, Baik SH. Robotic rectal surgery: what are the benefits? Minerva Chir 2013;68:457-69.
5. Ress AM, Benacci JC, Sarr MG. Efficacy of intraoperative enteroscopy in diagnosis and prevention of recurrent occult gastrointestinal bleeding. Am J Surg 1992;163:94-9. Crossref
6. Yoshiya S, Sugimachi K, Nakamura S, et al. Preoperative diagnostic value of single-balloon enteroscopy for successful surgical treatment of three independent-origin gastrointestinal malignant tumors: report of a case. Surg Today 2011;41:1007-10. Crossref
7. Upchurch BR, Sanaka MR, Lopez AR, Vargo JJ. The clinical utility of single-balloon enteroscopy: a single-center experience of 172 procedures. Gastrointest Endosc 2010;71:1218-23. Crossref
8. Tsujikawa T, Saitoh Y, Andoh A, et al. Novel single-balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences. Endoscopy 2008;40:11-5. Crossref
9. Domagk D, Mensink P, Aktas H, et al. Single- vs. double-balloon enteroscopy in small-bowel diagnostics: a randomized multicenter trial. Endoscopy 2011;43:472-6. Crossref

Fatal bilateral lower-limb deep vein thrombosis and pulmonary embolism following single digit replantation

DOI: 10.12809/hkmj144262
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
CASE REPORT
Fatal bilateral lower-limb deep vein thrombosis and pulmonary embolism following single digit replantation
Anderson SM Leung, MB, BS, MHKICBSC; Margaret WM Fok, FRCSEd(Orth), FHKAM (Orthopaedic Surgery); Boris KK Fung, FRCSEd(Orth), FHKAM (Orthopaedic Surgery)
Department of Orthopaedics and Traumatology, Queen Mary Hospital, Pokfulam, Hong Kong
Corresponding author: Dr Margaret WM Fok (margaret_fok@yahoo.com)
 
 Full paper in PDF
Abstract
Venous thromboembolism in hand surgery is rare. There is no report in the literature on postoperative mortality from venous thromboembolism following microsurgery in upper limbs. We report the case of a 56-year-old Chinese man who died from pulmonary embolism as a result of bilateral lower-limb deep vein thrombosis following prolonged surgery under general anaesthesia after replantation of a finger. This case raises awareness of the need for precautions against venous thromboembolism following prolonged microsurgery and identification of high-risk patients.
 
 
 
Introduction
Venous thromboembolism (VTE) is a condition that includes both deep vein thrombosis (DVT) and pulmonary embolism (PE). The formation of thrombi is associated with the Virchow’s triad, ie circulatory stasis, vascular wall injury, and a hypercoagulable state. Most data of VTE in orthopaedic surgeries are based on studies of patients who undergo hip or knee arthroplasty. The risk of VTE following lower-limb surgery is noted to be considerably higher than those following upper-limb surgery. To date, there has been no evidence to support the prescription of VTE prophylaxis in upper-limb operations.
 
Case report
In June 2013, a 56-year-old, non-obese, Chinese carpenter, who enjoyed good past health and was a non-smoker, sustained injuries to both his left ring finger and little finger while using an electric saw. His left ring finger was amputated at the level of the middle phalanx and his little finger was nearly amputated at the distal interphalangeal joint level. No other site of injury was noted (Fig a). He presented to our hospital 1 hour after the injury. Upon arrival he was haemodynamically stable.
 

Figure. (a) Amputated left ring finger and near-amputated left little finger. (b) Left ring finger stump with severe soft tissue contamination
 
Due to the severe soft tissue contamination of the finger stumps (Fig b), options of either replantation or revision amputation for the ring finger was discussed with the patient. Subsequent emergency operation was arranged for attempted replantation of his ring finger, and wound debridement and fixation of his left little finger. Revascularisation of the ring finger was attempted thrice, including use of a vein graft. However, due to the inability to achieve sustained blood flow to the amputated stump, revision amputation was performed. Meanwhile, the open wound of the little finger was debrided, and the fracture of the finger was temporarily fixed with axial K wire. The operation lasted 6 hours 25 minutes, with a total anaesthetic time of 7 hours 12 minutes. The fluid balance was +2450 mL. He regained full consciousness in the recovery room, with good breathing and oxygen saturation. Antibiotics were continued and he was transferred back to a general ward.
 
The operation was completed at 4 am the next day and his vital signs remained stable throughout. He offered no complaints in the morning round and was able to mobilise and walk to the washroom where he sustained an unwitnessed fall. He had neither preceding chest pain, headache, nor swelling and pain over his lower limbs, and did not lose consciousness. He developed tachycardia, tachypnoea, and desaturation after being helped to his bed. Echocardiogram revealed sinus tachycardia. He started developing chest discomfort with subsequent witnessed arrest 40 minutes later. Cardiac monitoring revealed pulseless electrical activity. Cardiopulmonary resuscitation was started immediately with injection of adrenaline. Bedside echocardiogram revealed no pericardial effusion but there was no response to resuscitation and the patient succumbed 35 minutes later. Postmortem examination revealed bilateral DVT in the calf muscles. Both lungs were markedly congested, with occluding thromboemboli noted in the hilar main pulmonary arteries and their main branches. No other thromboemboli were noted.
 
Discussion
Lower limb surgery is a risk factor for VTE events. The prevalence of DVT in patients who undergo hip fracture surgery and hip or knee arthroplasty ranges from 40% to 60%.1 2 Clinical or fatal PE in Hong Kong Chinese patients is even rarer.2
 
With regard to VTE following upper-limb surgery, nine VTE events have been reported. These comprised seven PEs following total elbow arthroplasty (of which three were fatal), one non-fatal PE after distal radius fixation following acute fracture, and one non-fatal PE following revision osteosynthesis of the proximal diaphysis of ulna.3 There has been no reported incidence in the literature of VTE following microsurgery.
 
It is difficult to determine whether microsurgery is completely risk-free for VTE. Prolonged surgery may involve prolonged immobilisation and blood loss that in turn increases the risk of VTE, based on Virchow’s triad. It is thus possible that prophylaxis for VTE is necessary in microsurgery when the operating time is expected to be long, for instance, in finger replantations or free-flap surgeries.
 
Currently there is no guideline on VTE prophylaxis for microsurgeries. The British Society for Surgery of the Hand4 considers upper-limb procedures under general anaesthesia for more than 90 minutes and/or with one risk factor for VTE (Box3) as moderate-risk procedures. It recommends use of mechanical compression devices in the operating room and/or until the patient becomes ambulatory. With the risk of bleeding in mind, low-molecular-weight heparin (LMWH) may be started no less than 6 hours postoperatively in selected patients and continued until they are fully ambulatory.3 None of these recommendations apply specifically to hand or microsurgeries.
 

Box. Risk factors for venous thromboembolism3
 
In addition to LMWH, the National Institute for Health and Care Excellence clinical guideline and the American College of Chest Physicians (ACCP) also mention the newer non–vitamin K antagonist oral anticoagulants (NOACs).5 This group of drugs is associated with a rapid onset of action and predictable pharmacokinetics and pharmacodynamics. There are also fewer interactions with food and other drugs. The ACCP recommends the use of VTE prophylaxis for a minimum of 10 to 14 days following major orthopaedic surgery. In patients who undergo total joint replacement, the ACCP suggests the use of LMWH in preference to other agents (eg fondaparinux, apixaban, dabigatran, rivaroxaban, low-dose unfractionated heparin, adjusted-dose vitamin K antagonist or aspirin), irrespective of the concomitant use of an intermittent pneumatic compression device. For those patients who refuse injections, apixaban or dabigatran is recommended. However, the available studies (eg RE-MODEL trial, RECORD trial and ADVANCE-2 study) and guidelines for VTE prophylaxis focus on total joint replacement surgeries.6 There are no recommendations on the use of NOACs in microsurgeries.
 
When prescribing VTE prophylaxis, it is important to balance the associated benefits and risks. In the case of mechanical compression, in view of its low-risk profile, it should be offered to all patients who undergo prolonged microvascular procedures, for example replantation, until they are fully ambulatory. The application of mechanical compression on both lower limbs may nonetheless be limited if donor sites for blood vessels and other tissues are anticipated from a lower limb.
 
Based on available evidence, we suggest that all patients who undergo microsurgery should have mechanical compression prophylaxis. Additional pharmacological prophylaxis should be considered for those who are at relatively high risk of developing VTE, for example, patients who have more than one risk factor, those in whom upper limb or tumour surgery will exceed 90-minute duration, and/or those in whom there will be prolonged postoperative immobilisation.
 
References
1. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):381S-453S.
2. Mok CK, Hoaglund FT, Rogoff SM, Chow SP, Ma A, Yau AC. The incidence of deep vein thrombosis in Hong Kong Chinese after hip surgery for fracture of the proximal femur. Br J Surg 1979;66:640-2. Crossref
3. Roberts DC, Warwick DJ. Venous thromboembolism following elbow, wrist and hand surgery: a review of the literature and prophylaxis guidelines. J Hand Surg Eur Vol 2014;39:306-12. Crossref
4. The British Society for Surgery of the Hand. VTE Guidelines. Available from: http://www.bssh.ac.uk/education/guidelines/vteguidelines. Accessed 2 Jul 2012.
5. Beyer-Westendorf J, Ageno W. Benefit-risk profile of non–vitamin K antagonist oral anticoagulants in the management of venous thromboembolism. Thromb Haemost 2015;113:231-46. Crossref
6. Saraf K, Morris P, Garg P, Sheridan P, Storey R. Non–vitamin K antagonist oral anticoagulants (NOACs): clinical evidence and therapeutic considerations. Postgrad Med J 2014;90:520-8. Crossref

Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: magnifying endoscopy findings

DOI: 10.12809/hkmj134208
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
CASE REPORT
Helicobacter pylori–negative gastric mucosa–associated lymphoid tissue lymphoma: magnifying endoscopy findings
TT Law, FRCSEd, FHKAM (Surgery); Daniel Tong, MS, PhD; Sam WH Wong, FRCSEd, FHKAM (Surgery); SY Chan, FRCSEd, FHKAM (Surgery); Simon Law, MS, FRCSEd
Division of Esophageal and Upper Gastrointestinal Surgery, Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong
Corresponding author: Prof Simon Law (slaw@hku.hk)
 Full paper in PDF
Abstract
Gastric mucosa–associated lymphoid tissue lymphoma is uncommon and most patients have an indolent clinical course. The clinical presentation and endoscopic findings can be subtle and diagnosis can be missed on white light endoscopy. Magnifying endoscopy may help identify the abnormal microstructural and microvascular patterns, and target biopsies can be performed. We describe herein the case of a 64-year-old woman with Helicobacter pylori–negative gastric mucosa–associated lymphoid tissue lymphoma diagnosed by screening magnification endoscopy. Helicobacter pylori–eradication therapy was given and she received biological therapy. She is in clinical remission after treatment. The use of magnification endoscopy in gastric mucosa–associated lymphoid tissue lymphoma and its management are reviewed.
 
 
 
Introduction
Primary extranodal low-grade B cell lymphoma of the mucosa-associated lymphoid tissue (MALToma) of stomach is uncommon. The clinical presentation is variable and there is no endoscopic hallmark. Magnifying endoscopy (ME) may help in the diagnosis of gastric MALToma. Herein we report the case of a patient who had gastric MALToma diagnosed by ME.
 
Case report
A 64-year-old woman had a history of cancer of alveolus that was in remission. She was considered at increased risk of developing squamous cell carcinoma of the upper aero-digestive tract; therefore, she was referred to us for endoscopic screening in May 2012. On white light endoscopy, a well-demarcated erythematous zone measuring 3 cm in size was identified at the distal greater curvature of the stomach (Fig 1a). To further delineate this suspicious lesion, ME combined with narrow-band imaging (NBI) was used. Magnifying endoscopy was performed with a zoom endoscope (GIF-Q260Z; Olympus Hong Kong and China Ltd, China) which has a magnifying power of 80 times. The tip of the endoscope was mounted with a transparent cap for the purpose of focusing. Under ME in combination with NBI, a non-structural area, ie, complete or almost-complete disappearance of gastric crypt epithelium and abnormal mucosal capillary pattern was identified (Fig 1a). Biopsy of the suspicious zone revealed atypical lymphoid cells with lymphoepithelial lesion formation. Immunohistochemical stains confirmed that the atypical lymphoid cells were positive for B cell marker CD20 (pan-B-cell marker: L26, Dako, UK), and negative for T cell markers CD3 and CD5 (Fig 2). Helicobacter pylori was not found. These findings were consistent with gastric MALToma. Whole-body positron-emission tomography scan did not show abnormal uptake in the stomach and the rest of body.
 
The patient was empirically treated with H pylori–eradication therapy (esomeprazole 20 mg twice daily, amoxicillin 1 g twice daily, and clarithromycin 500 mg twice daily for 1 week). She was then treated with four doses of rituximab (weekly for 4 weeks); this treatment was completed in June 2012. Repeated endoscopy and biopsy at 4 weeks after treatment showed a residual focus of MALToma. Radiotherapy (30 Gy) was subsequently given for improved local control in view of partial response to rituximab, which was completed in December 2012. Endoscopy performed 6 weeks after completion of radiotherapy showed complete response, ie, recovery of gastric pit pattern under ME (Fig 1b).
 

Figure 1. White light endoscopic images (upper) and magnified endoscopic images (lower)
(a) Magnified endoscopic image before treatment showing disappearance of the normal gastric pit pattern and appearance of irregular abnormal vessels (arrows). (b) Magnified endoscopic image after treatment showing recovery of gastric pits
 

Figure 2. Histopathology before treatment
(a) The atypical lymphoid cells form lymphoepithelial lesions. They show pale cytoplasm and mildly irregular hyperchromatic nuclei (H&E; original magnification, x 40). (b) The atypical lymphoid cells are diffusely positive for B cell marker CD20
 
Discussion
Gastric MALToma is uncommon and accounts for 1% to 5% of all gastric cancers. Isaacson and Wright1 first reported a low-grade gastric lymphoma in 1983. Lymphoid tissue is absent in the normal gastric mucosa. Helicobacter pylori is believed to play a causative role in the development of gastric MALToma.2 Gastric lymphoid tissue is acquired in response to local infection by H pylori, and there is a strong association between H pylori infection and gastric MALToma. Approximately 90% of gastric MALTomas are H pylori positive. Pathogenesis of gastric MALToma is a multistep process; H pylori infection causes chronic gastritis, which leads to immunological reaction with formation of lymphoid follicles and, subsequently, to genetic abnormalities and malignant transformation. Eradication of H pylori may lead to remission in 50% to 90% of cases.3 4 Most patients with gastric MALToma have an indolent clinical course; the 5-year overall survival after H pylori eradication has been reported to be 82% to 96%.5 6
 
The presentation of MALToma is variable. Patients may present with non-specific symptoms such as epigastric pain, vomiting, and weight loss. Endoscopy with biopsy is diagnostic but there is no endoscopic hallmark. The endoscopic appearance is also non-specific. It is difficult to differentiate gastric MALToma from gastric erosion or gastritis on conventional white light endoscopy. Diagnosis can be easily missed if multiple biopsies are not taken. Narrow-band imaging allows enhanced visualisation of microvascular and microsurface structures in the superficial part of the mucosa. The use of ME with NBI is useful for the diagnosis of early gastric cancer.7 Recently, retrospective studies have shown the characteristics of gastric MALToma on ME. Chiu et al8 reported abnormal spider-like vasculature and disappearance of gastric pits in nine patients with histological diagnoses of gastric MALToma, while Ono et al9 reported that non-structural areas with abnormal vessels were observed in 11 patients before treatment. The use of ME may help the endoscopist to take targeted biopsies from the abnormal areas.10
 
The histological criteria of gastric MALToma were established according to the World Health Organization criteria in 2001, which included (i) invasion of epithelial structures resulting in ‘lymphoepithelial lesions’; (ii) small lymphocytes, marginal zone cells, and/or monocytoid B cells; (iii) infiltration of diffuse, perifollicular, interfollicular, or even follicular type due to colonisation of reactive follicles.11
 
Surgery has been replaced by medical therapy in the management of gastric MALToma.12 It is generally recommended that H pylori–eradication therapy be the first-line therapy for H pylori–positive patients with localised gastric MALToma; eradication therapy should also be given to H pylori–negative patients, as there may be false-negative results.13 About 60% to 90% of patients with gastric MALToma achieve complete response after H pylori eradication.13 The presence of atrophic-like mucosa is a characteristic finding after treatment of gastric MALToma. Reported post-treatment ME findings include recovery of gastric pits and resolution of abnormal vascular pattern.8 It was demonstrated that the disappearance of non-structural areas with abnormal vessels was related to pathological remission.10
 
There is no consensus on treatment for those who fail to respond to eradication therapy. It is evident that patients with progressive disease or clinically evident relapse should undergo further treatment. Different treatment modalities include chemotherapy and radiotherapy. In a recently published multicentre cohort, high response rate to radiotherapy (94%) and chemotherapy (88%) was reported when used as second-line treatment in 82 non-responders and eight responders with relapse.14 Nine patients (out of 420 patients) showed transformation into diffuse large B cell lymphoma at a median follow-up period of 6 years.14 The management of patients with clinically partial remission is not well defined. A ‘watch and wait’ strategy has been advocated, and patients are followed up with interval endoscopies for evidence of progressive disease before considering oncological treatment.14 Rituximab, a chimeric antibody directed against CD20, is another therapeutic option. CD20 is a B cell–specific antigen expressed abundantly by the neoplastic cells of MALToma. The response rate has been reported to be around 70% in small series.15
 
In summary, patients with gastric MALToma present with non-specific symptoms, and there is no endoscopic hallmark. Endoscopy and biopsy are the gold standard for diagnosis. Magnifying endoscopy findings in MALToma include abnormal vessel patterns and disappearance of gastric pits; however, these findings have not been confirmed by large-scale prospective studies. Helicobacter pylori eradication is the first-line treatment. While the majority of patients respond to eradication therapy, those who fail to respond and develop progressive disease require oncological treatment. The management of partial responders is uncertain. Surveillance endoscopy is recommended in the follow-up of patients with MALToma in order to detect relapse.
 
Acknowledgement
We thank Dr Florence Loong (Department of Pathology, The University of Hong Kong Li Ka Shing Faculty of Medicine, Queen Mary Hospital) of providing the histopathology slides.
 
References
1. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983;52:1410-6. Crossref
2. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori–associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6. Crossref
3. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7. Crossref
4. Zullo A, Hassan C, Cristofari F, et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 2010;8:105-10. Crossref
5. Stathis A, Chini C, Bertoni F, et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol 2009;20:1086-93. Crossref
6. Zullo A, Hassan C, Andriani A, et al. Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis. Am J Gastroenterol 2009;104:1932-7. Crossref
7. Yao K, Oishi T, Matsui T, Yao T, Iwashita A. Novel magnified endoscopic findings of microvascular architecture in intramucosal gastric cancer. Gastrointest Endosc 2002;56:279-84. Crossref
8. Chiu PW, Wong TC, Teoh AY, et al. Recognition of changes in microvascular and microstructural patterns upon magnifying endoscopy predicted the presence of extranodal gastric MALToma. J Interv Gastroenterol 2012;2:3-7. Crossref
9. Ono S, Kato M, Ono Y, et al. Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment. Gastrointest Endosc 2008;68:624-31. Crossref
10. Ono S, Kato M, Ono Y, et al. Target biopsy using magnifying endoscopy in clinical management of gastric mucosa-associated lymphoid tissue lymphoma. J Gastroenterol Hepatol 2011;26:1133-8. Crossref
11. Isaacson PG, Muller-Hermelink HK, Paris MA, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001: 157-60.
12. Avilés A, Nambo MJ, Neri N, et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann Surg 2004;240:44-50. Crossref
13. Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004;53:34-7. Crossref
14. Nakamura S, Sugiyama T, Matsumoto T, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 2012;61:507-13. Crossref
15. Martinelli G, Laszlo D, Ferreri AJ, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin’s lymphoma resistant to or not eligible for anti–Helicobacter pylori therapy. J Clin Oncol 2005;23:1979-83. Crossref

Isolated spinal artery aneurysm: a rare culprit of subarachnoid haemorrhage

DOI: 10.12809/hkmj144230
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
CASE REPORT
Isolated spinal artery aneurysm: a rare culprit of subarachnoid haemorrhage
Tony HT Sung, MB, ChB, FRCR; Warren KW Leung, FHKCR, FHKAM (Radiology); Bill MH Lai, MB, BS, FRCR; Jennifer LS Khoo, FHKCR, FHKAM (Radiology)
Department of Radiology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong
Corresponding author: Dr Tony HT Sung (sht557@ha.org.hk), (tttony100@gmail.com)
 Full paper in PDF
Abstract
Isolated spinal artery aneurysm is a rare lesion which could be accountable for spontaneous spinal subarachnoid haemorrhage. We describe the case of a 74-year-old man presenting with sudden onset of chest pain radiating to the neck and back, with subsequent headache and confusion. Initial computed tomography aortogram revealed incidental finding of subtle acute spinal subarachnoid haemorrhage. A set of computed tomography scans of the brain showed further acute intracranial subarachnoid haemorrhage with posterior predominance, small amount of intraventricular haemorrhage, and absence of intracranial vascular lesions. Subsequent magnetic resonance imaging demonstrated a thrombosed intradural spinal aneurysm with surrounding sentinel clot, which was trapped and excised during surgical exploration. High level of clinical alertness is required in order not to miss this rare but detrimental entity. Its relevant aetiopathological features and implications for clinical management are discussed.
 
 
 
Introduction
Aneurysmal subarachnoid haemorrhage (SAH) is an uncommon but fatal clinical event. The reported incidence in a recent international population-based epidemiological study ranged between 2 and 16 per 100 000 population,1 and the mortality rate ranged from 8% to 67%.2 Among all SAH cases, less than 1% are considered to originate from the spine.3 We present a case of isolated spinal artery aneurysm as a rare culprit of spinal and intracranial SAH to illustrate the diagnostic challenge, its relevant aetiopathological features, and implications for clinical management.
 
Case report
A 74-year-old Chinese man with a history of hypertension and ischaemic heart disease presented to the Accident and Emergency Department in February 2013 for sudden onset of chest pain radiating to the neck and back. Clinical examination and electrocardiogram on admission showed no evidence of myocardial infarction. Initial working diagnosis of acute aortic dissection was also excluded with urgent computed tomography (CT) aortogram. On retrospective analysis, subtle but definite hyperdensities within the thecal sac at upper thoracic levels were noted, suggestive of acute spinal SAH (Fig 1).
 

Figure 1. (a, b) Axial and (c) coronal reformatted images of the contrast computed tomography (CT) aortograms demonstrate subtle hyperdensities within the dural sac at upper thoracic levels, suggesting acute spinal subarachnoid haemorrhage (arrows). The cerebrospinal fluid in normal subjects should be hypodense, similar to water attenuation on CT. The spinal cord is outlined as a central elongated hypodense structure simulating a contrast myelogram
 
The patient developed gradual progressive headache and confusion requiring intubation on the fourth day of admission. Plain CT of the brain at that time revealed further diffuse acute SAH with predominance over the posterior aspect, as well as a small amount of acute intraventricular haemorrhage. No skull vault fracture was observed. Concurrent CT cerebral arteriogram and venogram did not demonstrate any aneurysms or venous sinus thrombosis. Subsequent digital subtraction angiogram (DSA) of cerebral arteries performed on the next day was unremarkable.
 
In view of posterior predominance of the intracranial SAH with negative cerebral angiograms, an urgent magnetic resonance imaging (MRI) of the brain and cervical spine (Fig 2) was performed for suspected subtle intracranial pathology and a spinal origin of SAH (observed rarely). A lobulated 8-mm intradural, extramedullary lesion with internal hypointense signal was seen at the T1/2 level abutting the lateral surface of the spinal cord. Trace contrast enhancement was noted within the lesion. Adjacent hyperintense signal and susceptibility artefacts within the dural sac were also observed, suggestive of sentinel clot formation. The spinal cord was displaced slightly by the lesion with associated mild cord oedema. Radiological differential diagnosis at this juncture included cavernoma, largely thrombosed spinal aneurysm, other exophytic haemorrhagic intramedullary tumour or slow-flow arteriovenous malformation (AVM).
 

Figure 2. (a) Axial T1-, (b) T2- and (c) post-contrast fat-suppressed T1-weighted magnetic resonance imaging (MRI) of the spine at T1 level shows a lobulated intradural, extramedullary hypointense lesion with subtle contrast enhancement (arrows) and surrounding hyperintense blood clot. The spinal cord (arrowheads) is displaced laterally with intramedullary T2-hyperintense oedema. Corresponding sagittal (d) T1-, (e) T2-, and (f) post-contrast fat-suppressed T1-weighted MRI of the spine also shows the lobulated intradural lesion and surrounding blood clot
 
Subsequent laminectomy and surgical exploration were performed for definitive diagnosis, which revealed a 7-mm saccular aneurysm surrounded by fibrin and an old haematoma from C7 to T2 level. The aneurysm arose from and was incorporated with the radicular artery at T1 level, showing internal partial thrombosis. The aneurysmal sac was trapped and carefully excised without jeopardising the rest of the arterial supply to the cord. The patient had good clinical recovery in postoperative rehabilitation with no further neurological complaints.
 
Discussion
Compared with more common causes of spinal SAH like AVM, dural arteriovenous fistula (dAVF) and haemorrhagic spinal cord tumours, spinal artery aneurysm remains a rare entity with a reported incidence of less than 1 in 3000 spinal angiograms, according to a large-scale review by Pia and Djindjian.4 Ever since the first case report on spinal aneurysm back in 1930,5 experience from various studies remains limited mainly to isolated case reports and case series with small sample sizes.
 
Spinal aneurysms are distinct from intracranial counterparts in several ways. First, they occur mostly along the course of their parent arteries which have a small calibre and are less affected by atherosclerosis.6 On the contrary, intracranial aneurysms are well known for their predilection for branching points of large-sized arteries which are more haemodynamically challenged. Second, spinal aneurysms tend to be small in size, whereas giant aneurysms are exclusively found intracranially, especially in patients with connective tissue disease. Third, many spinal aneurysms are found to be dissecting aneurysms in histology, which explains their fusiform shape and lack of a surgical neck.5 This hinders direct surgical clipping during treatment planning.
 
For aetiology, isolated spinal aneurysms, as in our case, are rare lesions. More commonly, they are associated with concomitant vascular lesions or occlusions which recruit the spinal artery as a collateral route for supplying and increasing local blood flow. This, in turn, imposes haemodynamic stress and induces aneurysm formation along the parent arteries. Reported associations include spinal cord AVM,7 dAVF,8 aortic coarctation,5 Moyamoya disease,9 and bilateral vertebral artery occlusion.10 Another group of spinal aneurysms is related to underlying vasculopathies. Common examples include collagen vascular disease such as rheumatoid arthritis,11 mycosis,12 and syphilis.5
 
The diagnosis of spinal artery aneurysm could be challenging and delayed due to its rarity. Most patients present with headache and backache related to aneurysmal rupture and SAH. Neurological deficits including paraparesis, quadriplegia, and cord compression have also been reported.13 As for investigations, MRI and DSA of the spine are sufficient to demonstrate the location and vascular anatomy of a spinal artery aneurysm on most occasions which, in turn, are valuable for treatment planning by neurosurgeons. The position of the aneurysm with respect to the spinal cord determines whether the anterior approach for transthoracic vertebrectomy or posterior laminectomy is most appropriate. In a large-scale literature review by Geibprasert et al,14 32 spinal artery aneurysms were studied, in which the majority (62.5%) arose from the anterior spinal artery. Origin from the radicular artery, as in our case, was scarcely seen (n=2). The authors also observed that posterior spinal artery aneurysms were predominantly isolated dissecting aneurysms. On the contrary, those from the anterior spinal artery are more diverse in aetiology, eg, related to candidiasis and connective tissue disease, which implies a non-surgical management approach with medical treatment for the underlying disorder. Even for isolated dissecting aneurysms from the anterior axis, surgical ligation or endovascular embolisation is still limited by increased risk of postoperative complications including spinal cord infarction due to possible compromise of the dominant arterial supply to the cord. Options of surgical approach include resection and wrapping of the aneurysmal sac, with possible microvascular reconstruction in individual cases. Rare cases of spontaneous complete healing of the dissecting aneurysm have been reported,12 but prompt treatment should not be delayed due to the associated severe complications.
 
Conclusion
Spinal artery aneurysms are rare culprits of SAH, with different morphological features of their intracranial counterparts. Associations with concurrent vascular lesions and vasculopathy are frequent, with a minority of cases being isolated in aetiology. Magnetic resonance imaging and DSA of the spine show their merit in delineating the location and vascular anatomy of a spinal artery aneurysm, which are key determinants in management planning. Surgical treatment should be prompt and performed cautiously in view of possible substantial neurological deficit when the arterial supply of the cord is jeopardised.
 
References
1. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009;8:355-69. Crossref
2. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009;8:635-42. Crossref
3. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007;369:306-18. Crossref
4. Pia HW, Djindjian R. Spinal angiomas: advances in diagnosis and therapy. Berlin: Springer Verlag; 1987.
5. Rengachary SS, Duke DA, Tsai FY, Kragel PJ. Spinal arterial aneurysm: case report. Neurosurgery 1993;33:125-9; discussion 129-30. Crossref
6. Leech PJ, Stokes BA, ApSimon T, Harper C. Unruptured aneurysm of the anterior spinal artery presenting as paraparesis. Case report. J Neurosurg 1976;45:331-3. Crossref
7. Konan AV, Raymond J, Roy D. Transarterial embolization of aneurysms associated with spinal cord arteriovenous malformations. Report of four cases. J Neurosurg 1999;90(1 Suppl):148-54.
8. Malek AM, Halbach VV, Phatouros CC, et al. Spinal dural arteriovenous fistula with an associated feeding artery aneurysm: case report. Neurosurgery 1999;44:877-80. Crossref
9. Walz DM, Woldenberg RF, Setton A. Pseudoaneurysm of the anterior spinal artery in a patient with Moyamoya: an unusual cause of subarachnoid hemorrhage. AJNR Am J Neuroradiol 2006;27:1576-8.
10. Kawamura S, Yoshida T, Nonoyama Y, Yamada M, Suzuki A, Yasui N. Ruptured anterior spinal artery aneurysm: a case report. Surg Neurol 1999;51:608-12. Crossref
11. Toyota S, Wakayama A, Fujimoto Y, Sugiura S, Yoshimine T. Dissecting aneurysm of the radiculomedullary artery originating from extracranial vertebral artery dissection in a patient with rheumatoid cervical spine disease: an unusual cause of subarachnoid hemorrhage. Case report. J Neurosurg Spine 2007;7:660-3. Crossref
12. Berlis A, Scheufler KM, Schmahl C, Rauer S, Götz F, Schumacher M. Solitary spinal artery aneurysms as a rare source of spinal subarachnoid hemorrhage: potential etiology and treatment strategy. ANJR Am J Neuroradiol 2005;26:405-10.
13. Yahiro T, Hirakawa K, Iwaasa M, Tsugu H, Fukushima T, Utsunomiya H. Pseudoaneurysm of the thoracic radiculomedullary artery with subarachnoid hemorrhage. Case report. J Neurosurg 2004;100(3 Suppl Spine):312-5.
14. Geibprasert S, Krings T, Apitzsch J, Reinges MH, Nolte KW, Hans FJ. Subarachnoid hemorrhage following posterior spinal artery aneurysm. A case report and review of the literature. Interv Neuroradiol 2010;16:183-90.

Acquired factor V inhibitor in a patient receiving venous-venous extracorporeal membrane oxygenation for Legionella pneumonia

DOI: 10.12809/hkmj134141
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
CASE REPORT
Acquired factor V inhibitor in a patient receiving venous-venous extracorporeal membrane oxygenation for Legionella pneumonia
Anne KH Leung, FHKCA, FHKAM (Anaesthesiology)1; George WY Ng, FHKCP, FHKAM (Medicine)1; KC Sin, FHKCP, FHKAM (Medicine)1; SY Au, FHKCP, FHKAM (Medicine)1; KY Lai, FHKCP, FHKAM (Medicine)1; KL Lee, FHKCP, FHKAM (Medicine)2; KI Law, FHKCP, FHKAM (Medicine)2
1 Intensive Care Unit, Queen Elizabeth Hospital, Jordan, Hong Kong
2 Intensive Care Unit, United Christian Hospital, Kwun Tong, Hong Kong
 
Corresponding author: Dr Anne KH Leung (leungkha@ha.org.hk)
 
 Full paper in PDF
Abstract
We report a rare complication of factor V deficiency in a patient having Legionella pneumonia. This patient also had other complications like severe acute respiratory distress syndrome, acute kidney injury, and septic shock that required venous-venous extracorporeal membrane oxygenation support. This is the first reported case of acquired factor V deficiency in a patient receiving extracorporeal membrane oxygenation for Legionella pneumonia. With the combined use of intravenous immunoglobulin, rituximab and plasma exchange, we achieved rapid clearance of the factor V inhibitor within 1 week so as to allow safe decannulation of extracorporeal membrane oxygenation.
 
 
Case report
This was the case of a 53-year-old lorry driver with a history of pulmonary tuberculosis and chronic smoking, who presented in December 2012 with fever, cough, and sputum. Chest X-ray (CXR) showed left lower zone consolidation; the patient was diagnosed to have community-acquired pneumonia which was treated with ceftriaxone and azithromycin. Two days later, both the renal and liver functions worsened with elevation of serum urea level to 23.2 mmol/L (reference range [RR], 8-8.1 mmol/L), creatinine level to 493 µmol/L (RR, 62-106 µmol/L), aspartate transaminase level to 300 IU/L (reference level [RL], <40 IU/L), and alanine transaminase level up to 94 IU/L (RL, <41 IU/L). There was severe rhabdomyolysis with increased serum creatine kinase levels to 11 010 IU/L (RR, 39-308 IU/L). Urine tested positive for Legionella antigen. Antibiotic was changed to piperacillin-tazobactam and azithromycin. The patient developed respiratory failure the next day and was admitted to the intensive care unit (ICU) for ventilator support. His condition gradually stabilised over the next 10 days and sputum culture showed growth of Legionella pneumophila serogroup 1.
 
By day 11 in the ICU, he developed secondary deterioration with rapid progression of pulmonary infiltrates on CXR, septic shock, and acute kidney injury. Sputum culture after ICU admission showed growth of Pseudomonas aeruginosa and Corynebacterium species. Antibiotic was changed to meropenem and levofloxacin. By day 12, his oxygenation could not be maintained with conventional ventilation and the Murray score was 3.5. The patient was referred for extracorporeal membrane oxygenation (ECMO) support.
 
As his condition was unstable for transfer to the ECMO centre, venous-venous ECMO (VV-ECMO) was initiated at the referring hospital by percutaneous placement of two ECMO cannulas (23F and 19F) into the femoral vein and right internal jugular vein, respectively. The ECMO circuitry consisted of the Quadrox-i hollow-fibre oxygenator and Cardiohelp centrifugal pump (Maquet Cardiopulmonary AG, Germany). The circuit flow was started at 3.2 to 2.8 L/min during the first ECMO day, and then subsequently increased to 4.0 to 5.0 L/min to achieve PaO2 of 8 to 10 kPa. The ventilator setting was then decreased to peak airway pressure of <25 cm H2O, positive end–expiratory pressure of 10 cm H2O and FiO2 of 0.4. Heparin was started according to protocol with bolus 70 unit/kg after cannulation, followed by continuous infusion at 10 unit/kg/h to achieve an activated clotting time (ACT) of 200 to 220 seconds. The coagulation profile, ACT, renal function, and arterial blood gas were monitored every 4 hours.
 
Before initiation of VV-ECMO, the baseline international normalised ratio (INR) was 1.1 and activated partial thromboplastin time (APTT) was 33.7 seconds (RR, 28-34.6 seconds). A full blood count showed a haemoglobin concentration of 68 g/L, white cell count of 16 x 109 /L, and a platelet count of 169 x 109 /L. Continuous veno-venous haemofiltration (CVVH) was started for renal support. By day 4 of ECMO, INR started to prolong (1.61) and gradually increased to 2.32 and 3.36 over the next 2 days. Heparin was stopped, and vitamin K 10 mg and repeated fresh frozen plasma (FFP) transfusions ranging from 8 to 14 units per day were given. Throughout this period, the fibrinogen level remained normal at 4.44 g/L (RR, 2-4.5 g/L) and platelet count was greater than 100 x 109 /L. Liver function and ammonia level were normal. The coagulopathy could not be corrected by FFP. A haematologist was consulted and further tests were arranged. By day 8, the INR peaked at 4.06, and APTT increased to 115 seconds with slight prolongation of thrombin time (TT) to 15.3 seconds (TT control = 14.4 seconds). Coagulation factor assay showed factor V of 1% (RR, 50-200%) while factor VII, VIII, IX, X, XI and XII levels were within reference intervals. Factor V inhibitor assay showed levels increased up to 6 Bethesda units. The diagnosis of acquired factor V inhibitors was made.
 
In the presence of significantly high levels of factor V inhibitor and risk of spontaneous intracranial bleed, intravenous immunoglobulin (IVIG) at 60 g/day was given for 2 days. The patient’s INR decreased from 3.96 to 2.56 and APTT decreased from 105.4 to 55.3 seconds. The workup for immune markers including C3, C4, rheumatoid factor, antinuclear antibody, antineutrophil cytoplasmic and perinuclear neutrophil antibodies, anti-extractable nuclear antigen, and anti-cardiolipin antibodies was negative. The tumour markers were negative as well. The patient received no surgical procedure. He had been put on four antibiotics after ECMO including azithromycin, meropenem, fluconazole, and linezolid. By day 4 of ECMO, fluconazole was replaced with anidulafungin for fungal cover.
 
Despite IVIG, the patient developed significant clinical bleeding with full-stream haematuria and bronchoscopy showed extensive blood clots in the left lower lobe. At the same time, his pulmonary mechanics and CXR started to improve after 10 days of ECMO support and he appeared ready to be weaned off from ECMO. It was decided to give him one dose of rituximab 700 mg on day 11 of ECMO. His INR decreased to 1.29 and APTT to 33.6 seconds over the next 2 days (Figs 1 and 2). The patient was successfully decannulated on day 13 of ECMO. The haematuria remained severe and required continuous bladder irrigation. Citrate CVVH was started for renal support. One session of plasma exchange was given after decannulation. The haematuria eventually stopped by day 16. Two days later, urinary output returned to normal and the patient was successfully extubated. By day 19, the patient was transferred back to the parent hospital with INR of 1.02, APTT of 30.4 seconds, and factor V assay of 173%. The patient was discharged 3 weeks later and his coagulation profile remained normal without further eradication therapy. At the time of discharge, the patient was able to walk with the help of a walking stick, could perform activities of daily living independently, and was dialysis-independent.
 

Figure 1. INR and APTT profiles of the patient during the 19-day stay at ECMO centre
 

Figure 2. Detailed INR and APTT profiles of the patient from day 8 to day 12
 
Discussion
Factor V deficiency: causes, clinical course, laboratory finding, treatment, and outcome
Factor V is a plasma cofactor that activates prothrombin to thrombin, thus, affecting the common final pathway of the coagulation cascade. About 20% of the circulating factor V is found within platelet α granules.1 The first reported case of congenital factor V deficiency was from Germany in 1955,2 and to date, about 200 reported cases have been reported.1 Congenital factor V deficiency is a rare autosomal recessive disease with a prevalence of 1 in 1 000 000.1 In acquired cases, it is related to the presence of factor V inhibitor.3 In one case series of 78 patients, the commonest cause was the use of antibiotics (42%), including β-lactam antibiotics, aminoglycosides, cephalosporins, tetracyclines, and quinolones. The next common cause was surgical procedure (31%) with exposure to bovine thrombin, which is a topical haemostatic agent widely used in cardiovascular or neurosurgical procedures.4 Infection, cancer, and autoimmune disease were present in 23%, 22%, and 13% of the cases, respectively. About 16 (21%) cases had no identifiable causes.3
 
The median age of presentation was 69 years, with a tendency for male predominance.3 Overall, 81% of cases had bleeding, and the mucous membranes of most frequently reported sites including gastro-intestinal tract, genito-urinary tract, and the airway were noted in up to 62% of cases.3 Cerebral haemorrhage occurred in only 8% of cases, but was associated with 50% mortality.3 Some cases were associated with thrombotic complications rather than haemorrhage.5
 
Laboratory findings included a prolonged prothrombin time and APTT that failed to be corrected by mixing studies. Thrombin time was usually normal unless there is presence of thrombin inhibitor. Bethesda assay is used to detect and quantify the presence of inhibitors. One Bethesda unit is defined as the amount that decreases factor V concentration by 50%.4 5 Bleeding correlated with factor V activity with median factor V activity being 1% in bleeders and 3% in non-bleeders.3
 
Treatment mainly consists of controlling bleeding and eradication of the autoantibody. Daily infusion of 15 to 20 mL/kg of FFP is usually sufficient.1 In refractory cases, recombinant factor VIIa, activated prothrombin complex concentrate, and platelet transfusion are therapeutic options.1 3 6 Plasmapheresis and immunoadsorption can rapidly reduce antibody titres. For immunosuppression, corticosteroids and cyclophosphamide have shown a success rate of 63%.3 Use of high-dose IVIG and anti-20 monoclonal antibody rituximab were associated with rapidly increasing factor V activity, although results were conflicting.3 6
 
The alloantibody against factor V was polyclonal immunoglobulin G7 and it disappeared in the majority of cases (69%) either after eradiation therapy (43/78 patients) or spontaneously (12/78 patients).3 7 For those patients who survived, factor V inhibitor persisted for a mean period of 5.1 months8 (range, <1 month to several years).6 7 For those related to bovine thrombin, the inhibitor emerged after a mean of 8.3 days of exposure and persisted for a shorter time of 2.3 months.8 Overall, 72% of patients with acquired factor V inhibitors suffered bleeding complications, with 17% of those being fatal.8 For those with acquired factor V deficiency with a known cause like bovine thrombin–induced factor V inhibitor, bleeding was less common (33%) and was associated with better prognosis and lower fatality (6%).8 The highest mortality was found in patients with autoimmune disorder (30%) or cancer (24%).3
 
Use of extracorporeal membrane oxygenation for Legionella pneumonia
Use of ECMO has been reported locally for treating influenza H1N1 with good outcome.9 Use of ECMO in Legionella pneumonia with acute respiratory distress syndrome has been reported,10 11 12 with survival rate ranging from 67% to 84% in the UK series.10 11 Acute renal failure was a common complication of legionellosis with 53.7% requiring renal replacement therapy. The prognosis for this subgroup of patients was poor with only 33% (vs 70% in those without acute renal failure) surviving to decannulation and mortality increasing from 15% to 53%.10 Major bleeding complications reported in these series included intra-abdominal bleeding, cardiac tamponade, chest drain–related haemorrhage, and gastro-intestinal and intracranial bleeding.9 10 11
 
This is the first reported case of acquired factor V inhibition in a patient put on VV-ECMO for Legionella pneumonia. Although our patient had acute renal failure and ECMO was instituted late in his course of illness (13 days after intubation), he responded favourably. The cause of the acquired factor V inhibition was uncertain. It may be related to the underlying infection, use of antibiotics, or be idiopathic in nature. The coagulopathy was not corrected by FFP transfusion and the patient had symptomatic bleeding with haematuria and pulmonary haemorrhage despite IVIG therapy. Although we could wait for the natural disappearance of the factor V inhibitor, it might prolong weaning from ECMO and increase the risk of fatal complications like intracranial bleeding. Yet, too early prescription of rituximab as in this patient might mask the effect of IVIG. Lastly, there was a remote possibility that the observed decrease in INR and APTT could be due to natural progression of the underlying disease rather than a treatment effect as only 15% of patients have spontaneous resolution of disease and the factor V inhibitors can persist in the body for months.3 6 7 In one case report, INR remained elevated for 10 days despite immunosuppressive therapy and returned to normal over the next 2 weeks.4 The need for ECMO decannulation and presence of active symptoms made correction of coagulopathy more imminent. The use of multimodal therapy including IVIG, rituximab, and plasma exchange in this patient successfully halted the progress of the factor V inhibitor and allowed safe decannulation within a period of 1 week.
 
References
1. Huang JN, Koerper MA. Factor V deficiency: a concise review. Haemophilia 2008;14:1164-9. Crossref
2. Horder MH. Isolated factor V deficiency caused by a specific inhibitor [in German]. Acta Haematol 1955;13:235-41.
3. Franchini M, Lippi G. Acquired factor V inhibitors: a systematic review. J Thromb Thrombolysis 2011;31:449-57. Crossref
4. Morris CJ, Curry N. Acquired factor V inhibitor in a critically ill patient. Anaesthesia 2009;64:1014-7. Crossref
5. Crookston K, Rosenbaum L, Gober-Wilcox J. Coagulation. Acquired bleeding disorders. Factor V inhibitor. Available from: http://www.pathologyoutlines.com/topic/coagulationfactorVinhibitor.html. Accessed Nov 2013.
6. Lu L, Liu Y, Wei J, Zhang L, Zhang L, Yang R. Acquired inhibitor of factor V: first report in China and literature review. Haemophilia 2004;10:661-4. Crossref
7. van Spronsen DJ, Oosting JD, Hoffmann JJ, Breed WP. Factor V inhibitor associated with cold agglutinin disease. Ann Hematol 1998;76:49-50. Crossref
8. Streiff MB, Ness PM. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 2002;42:18-26. Crossref
9. Chan KK, Lee KL, Lam PK, Law KI, Joynt GM, Yan WW. Hong Kong’s experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1). Hong Kong Med J 2010;16:447-54.
10. Bryner B, Miskulin J, Smith C, et al. Extracorporeal life support for acute respiratory distress syndrome due to severe Legionella pneumonia. Perfusion 2014;29:39-43. Crossref
11. Noah MA, Ramachandra G, Hickey MM, et al. Extracorporeal membrane oxygenation and severe acute respiratory distress secondary to Legionella: 10 year experience. ASAIO J 2013;59:328-30.
12. Harris DJ, Duke GJ, McMillan J. Extracorporeal membrane oxygenation for Legionnaires disease: a case report. Crit Care Resusc 2002;4:28-30.
 

Unexplained childhood anaemia: idiopathic pulmonary hemosiderosis

DOI: 10.12809/hkmj144237
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
CASE REPORT
Unexplained childhood anaemia: idiopathic pulmonary hemosiderosis
KK Siu, MB, ChB, MRCPCH1; Rever Li, MB, ChB, FHKAM (Paediatrics)2; SY Lam, MB, BS, FHKAM (Paediatrics)2
1 Department of Paediatrics, Kwong Wah Hospital, Yaumatei, Hong Kong
2 Department of Paediatrics, Tuen Mun Hospital, Tuen Mun, Hong Kong
 
Corresponding author: Dr KK Siu (skk053@ha.org.hk)
 
 Full paper in PDF
Abstract
This report demonstrates pulmonary haemorrhage as a differential cause of anaemia. Idiopathic pulmonary hemosiderosis is a rare disease in children; it is classically described as a triad of haemoptysis, pulmonary infiltrates on chest radiograph, and iron-deficiency anaemia. However, anaemia may be the only presenting feature of idiopathic pulmonary hemosiderosis in children due to occult pulmonary haemorrhage. In addition, the serum ferritin is falsely high in idiopathic pulmonary hemosiderosis which increases the diagnostic difficulty. We recommend that pulmonary haemorrhage be suspected in any child presenting with iron-deficiency anaemia and persistent bilateral pulmonary infiltrates.
 
 
Case report
We report the case of a 5-year-old boy, who presented with recurrent episodes of unexplained iron-deficiency anaemia in February 2010 since the age of 27 months. Serial chest X-rays (CXRs) showed bilateral reticulonodular haziness. Bronchoalveolar lavage and lung biopsy confirmed the diagnosis of idiopathic pulmonary hemosiderosis (IPH).
 
The patient first presented at 27 months of age in Mainland China with malaise, loss of appetite, and shortness of breath for 10 days. He did not have fever, cough, or haemoptysis. He received two doses of H1N1 vaccination before pallor was noted. There was no history of drug or herb intake.
 
The presenting haemoglobin (Hb) level was 65 g/L (reference range [RR], 115-145 g/L), mean corpuscular volume (MCV) 84.4 fL (RR, 76-90 fL), mean corpuscular haemoglobin (MCH) level 25.8 pg (RR, 25-31 pg), and reticulocyte count 10.4% (reference level [RL], <2%). White cell count and platelet count were unremarkable. Blood smear showed moderate anisopoikilocytosis with polychromasia. Bone marrow aspiration and trephine biopsy revealed active marrow with erythroid preponderance.
 
Other investigations were performed for anaemia. Serum lactate dehydrogenase (LDH) level was elevated to 980 U/L (RL, <615 U/L). Haptoglobin level was reduced (<0.09 g/L; RR, 0.3-2.7 g/L). Direct Coombs test was negative. Bilirubin was normal. Urine for bilirubin and urobilinogen was negative. Haemoglobin pattern, serum vitamin B12, and G6PD activity were unremarkable. Serum ferritin level was 137 pmol/L (RR, 45-449 pmol/L). Antinuclear antibody assay was negative. Flow cytometry showed normal expression of CD55 and CD59 which ruled out paroxysmal nocturnal haemoglobinuria. Donath-Landsteiner antibody assay was negative, which excluded the diagnosis of paroxysmal cold haemoglobinuria.
 
Blood work for viral infection including antibodies to parvovirus, Epstein-Barr virus (EBV), mycoplasma, and viral titres was unremarkable.
 
Screening for blood loss was negative. Stool for occult blood and urine for Hb were negative. Red blood cell scan showed no evidence of haemorrhage.
 
Blood transfusion was given to correct the anaemia. Microcytic hypochromic anaemia was noted at 2 months after presentation. Haemoglobin level was 54 g/L. Mean corpuscular volume dropped from 84.4 fL to 68 fL. Mean corpuscular haemoglobin level was 21.3 pg. Iron profile showed a low serum iron level of 3 µmol/L (RR, 5-20 µmol/L), elevated total iron-binding capacity (TIBC) of 70 µmol/L (RR, 37-68 µmol/L), and iron saturation of 4% (RR, 20-55%). However, the serum ferritin level was normal at 220 pmol/L (RR, 45-449 pmol/L). Iron supplement was started as a therapeutic trial for suspected iron-deficiency anaemia.
 
His Hb level remained stable in the next 2 years. However, in the subsequent 8 months, there were three intermittent episodes of anaemia (lowest Hb level, 60 g/L). The anaemia occurred with fever and cough which were considered symptoms of pneumonia and upper respiratory tract infection. There was no history of haemoptysis.
 
At 36 months after the presentation, he was admitted again for pallor, fatigue, and fever. This time, he needed oxygen therapy. Chest was clear with mild subcostal insucking. Hepatomegaly of 4 cm below the costal margin was noted. Chest X-ray showed bilateral reticulonodular haziness (Fig 1). Haemoglobin level was 61 g/L. Both MCV (78 fL) and MCH level (25 pg) were in the lower normal limits. The serum ferritin level was 879 pmol/L. A diagnosis of pneumonia was made; he was started on oral co-amoxiclav (amoxicillin and clavulanic acid) and azithromycin and given blood transfusion. Fever subsided and oxygen was weaned off. Ultrasonography of abdomen performed 1 month later showed no hepatomegaly; mild hepatic coarsening was suggestive of parenchymal disease. Liver function tests were normal all along. However, the patient tested positive for EBV immunoglobulin (Ig) M antibodies. Thus, he was diagnosed to have pneumonia with EBV infection.
 

Figure 1. A chest X-ray showing bilateral reticulonodular haziness
 
Review of old CXRs showed similar reticulonodular shadows. In view of his history of recurrent iron-deficiency anaemia and CXR findings, pulmonary hemosiderosis was suspected. Flexible bronchoscopy was performed; bronchoscopic lavage over left lingular and right middle lobe showed blood-stained fluid. Bronchoalveolar lavage yielded abundant hemosiderin-laden macrophages (HLM index, 92%). High-resolution computed tomography of thorax showed extensive ground glass opacities and reticular shadows, suggestive of interstitial lung disease. Diffuse visceral pleural brownish deposits were noted over the entire left lung on video-assisted thoracoscopy. Lung biopsy was performed to rule out systemic disorders with pulmonary capillaritis, which could cause diffuse alveolar haemorrhage (DAH). These included Goodpasture’s syndrome, IgA nephropathy, Wegener’s granulomatosis, systemic lupus erythematosus, and antiphospholipid syndrome. Biopsy of lung tissue showed numerous HLM. There was no evidence of capillaritis or vasculitis. Absence of fibrosis and negative exposure history also excluded hypersensitivity pneumonitis. Immunostaining for IgG, IgM, and IgA was negative. The overall picture was compatible with pulmonary hemosiderosis.
 
Further blood investigations were performed to exclude systemic causes of pulmonary haemorrhage as stated above. Antiglomerular basement membrane antibodies, rheumatoid factor, anti-neutrophil cytoplasmic antibodies, antinuclear antibodies, anti-extractable nuclear antibodies, and anti-cardiolipin IgG antibodies were not detected. Furthermore, the patient was negative for anti-transglutaminase antibody for coeliac disease. He tested weakly positive for IgE antibodies against cow’s milk. Immunoglobulin pattern was unremarkable apart from mildly raised IgA antibody level at 2.28 g/L (range, 0.5-1.92 g/L). Renal function and urinalysis were normal.
 
A diagnosis of IPH was made based on the above findings. Oral prednisolone was started after the diagnosis for disease control. Chest X-ray performed after 3 months of prednisolone showed improvement in reticulonodular densities (Fig 2). We plan to monitor the disease with clinical symptoms, Hb levels, LDH levels, CXRs, and spirometry.
 

Figure 2. A chest X-ray performed after 3 months of prednisolone therapy showing improvement in reticulonodular densities
 
Discussion
Idiopathic pulmonary hemosiderosis is a rare disease in children with an unknown aetiology. The estimated yearly incidence among Swedish children from 1960 through 1979 was 0.24 per 1 000 000 children.1 A retrospective review of records from a tertiary paediatric hospital in northern Taiwan noted five cases over 25 years.2 Patients classically presented with a triad of recurrent or chronic pulmonary symptoms (cough, dyspnoea, wheeze, haemoptysis), pulmonary infiltrates on CXR, and iron-deficiency anaemia. Our patient had only anaemia without obvious underlying causes. Subsequent CXR changes led to the suspicion of IPH.
 
Serum ferritin has been traditionally taken as a reliable surrogate marker of body iron stores. Hypoferritinaemia is commonly used as a diagnostic marker for iron deficiency.3 However, as it is an acute-phase reactant, abnormally raised serum ferritin level may be seen during acute infection or liver disease even in the presence of iron deficiency.4 In IPH, iron study usually shows low serum iron with low iron saturation, and microcytosis and hypochromia in the blood picture. However, plasma ferritin level can be normal or elevated in IPH because of alveolar synthesis and release into the circulation and does not reflect the iron deposits in the body.5 This makes the diagnosis of iron-deficiency anaemia in IPH difficult. We recommend the use of serum iron and transferrin saturation (serum iron/TIBC) instead to evaluate suspected iron-deficiency anaemia.4
 
Diagnosis of IPH is based on exclusion of other causes of intrapulmonary haemorrhage and systemic diseases. In the absence of systemic disease, findings of HLM in bronchoscopic lavage or gastric aspirate/sputum along with chronic pulmonary symptoms lead to a diagnosis of IPH. Lung biopsy is the gold standard for diagnosis. We performed lung biopsy to exclude pulmonary capillaritis, which is one of the causes of DAH. Pulmonary capillaritis is a small-vessel vasculitis, which can occur as an isolated condition or in association with multiple systemic vasculitides. Isolated DAH without identifiable causation or associated disease is referred to as IPH.6
 
Daily oral corticosteroids or weekly intravenous pulse methylprednisolone is commonly used in the induction treatment of IPH. Other immunosuppressive agents such as azathioprine, cyclophosphamide, and hydroxychloroquine have also been used alone or in combination with oral corticosteroids.7 8 9 10 11 Low-dose oral corticosteroids, azathioprine, or methotrexate are used in maintenance phase. As there is lack of large patient series and inadequate follow-up in previous studies, the prognosis of IPH remains unclear. However, aggressive treatment with the use of corticosteroids and immunosuppressive agents are associated with a prolonged survival and improved prognosis.12 Long-term low-dose corticosteroid therapy was also reported to result in a milder disease course and prevent bleeding crisis.13
 
In conclusion, iron-deficiency anaemia results from poor dietary intake of iron in infants and toddlers. However, every child older than 24 months presenting with iron-deficiency anaemia should be evaluated for chronic blood loss. In this report, we have illustrated that anaemia without any respiratory symptoms can be the sole presenting feature of IPH, preceding other signs and symptoms, especially in young children. Haemoptysis may not be present in young children with IPH, as they tend to swallow their sputum. We recommend that when children present with unexplained anaemia and bilateral lung infiltrations, pulmonary haemorrhage should be suspected.
 
References
1. Kjellman B, Elinder G, Garwicz S, Svan H. Idiopathic pulmonary haemosiderosis in Swedish children. Acta Paediatr Scand 1984;73:584-8. Crossref
2. Yao TC, Hung IJ, Wong KS, Huang JL, Niu CK. Idiopathic pulmonary haemosiderosis: an Oriental experience. J Paediatr Child Health 2003;39:27-30. Crossref
3. Rybo E. Diagnosis of iron deficiency. Scand J Haematol Suppl 1985;43:5-39.
4. Li CH, Lee AC, Mak TW, Szeto SC. Transferrin saturation for the diagnosis of iron deficiency in febrile anaemic children. Hong Kong Pract 2003;25:363-6.
5. Ioachimescu OC, Sieber S, Kotch A. Idiopathic pulmonary haemosiderosis revisited. Eur Respir J 2004;24:162-70. Crossref
6. Fullmer JJ, Langston C, Dishop MK, Fan LL. Pulmonary capillaritis in children: a review of eight cases with comparison to other alveolar hemorrhage syndromes. J Pediatr 2005;146:376-81. Crossref
7. Milman N, Pedersen FM. Idiopathic pulmonary haemosiderosis. Epidemiology, pathogenic aspects and diagnosis. Respir Med 1998;92:902-7. Crossref
8. Rossi GA, Balzano E, Battistini E, et al. Long-term prednisolone and azathioprine treatment of a patient with idiopathic pulmonary hemosiderosis. Pediatr Pulmonol 1992;13:176-80. Crossref
9. Colombo JL, Stolz SM. Treatment of life-threatening primary pulmonary hemosiderosis with cyclophosphamide. Chest 1992;102:959-60. Crossref
10. Zaki M, al Saleh Q, al Mutari G. Effectiveness of chloroquine therapy in idiopathic pulmonary hemosiderosis. Pediatr Pulmonol 1995;20:125-6. Crossref
11. Bush A, Sheppard MN, Warner JO. Chloroquine in idiopathic pulmonary haemosiderosis. Arch Dis Child 1992;67:625-7. Crossref
12. Saeed MM, Woo MS, MacLaughlin EF, Margetis MF, Keens TG. Prognosis in pediatric idiopathic pulmonary hemosiderosis. Chest 1999;116:721-5. Crossref
13. Kiper N, Göçmen A, Ozçelik U, Dilber E, Anadol D. Long-term clinical course of patients with idiopathic pulmonary hemosiderosis (1979-1994): prolonged survival with low-dose corticosteroid therapy. Pediatr Pulmonol 1999;27:180-4. Crossref
 

From observation to aetiology: a case report of a twin fetus-in-fetu and a revisit of the known rarity

DOI: 10.12809/hkmj133925
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
CASE REPORT
From observation to aetiology: a case report of a twin fetus-in-fetu and a revisit of the known rarity
Kristine KY Pang, MB, ChB, MRCSEd1; Nicholas SY Chao, FCSHK, FHKAM (Surgery)1; TK Tsang, FHKAM (Radiology)2; Betty YT Lau, FHKAM (Obstetrics and Gynaecology)3; KY Leung, FHKAM (Obstetrics and Gynaecology)3; SH Ting, MB, BS4; Michael WY Leung, FCSHK, FHKAM (Surgery)1; Kelvin KW Liu, FCSHK, FHKAM (Surgery)5;
1 Division of Paediatric Surgery, Department of Surgery, Queen Elizabeth Hospital, Jordan, Hong Kong
2 Department of Radiology and Imaging, Queen Elizabeth Hospital, Jordan, Hong Kong
3 Department of Obstetrics and Gynaecology, Queen Elizabeth Hospital, Jordan, Hong Kong
4 Department of Pathology, Queen Elizabeth Hospital, Jordan, Hong Kong
5 Division of Paediatric Surgery, Department of Surgery, United Christian Hospital, Kwun Tong, Hong Kong
 
Corresponding author: Dr Nicholas SY Chao (nickchao@yahoo.com)
 
 Full paper in PDF
Abstract
A baby girl presented with an antenatal diagnosis of a retroperitoneal tumour. Postnatal imaging suggested that this mass contained two fetiform structures with spine and long bone formation. This teratomatous mass was completely excised at 3 weeks of age. Histology was consistent with twin fetuses-in-fetu, revealing two fetiform masses each with an umbilical cord connecting to a common placenta-like mass. Despite a difference in the weight of the twin fetuses-in-fetu, the level of organogenesis was identical and corresponded to fetuses of 10 weeks of gestation. Each mass had four limbs, intact skin, rib cage, intestines, anus, ambiguous genitalia, primitive brain tissue and a spine with ganglion cells in the cord. Although considered a mature teratoma in the current World Health Organization classification, the theory of formation from multiple pregnancies has been commonly implied in more recent literature. The true aetiology of this rare condition remains unclear.
 
 
Introduction
Fetus-in-fetu is a rare condition with an estimated incidence of 1 in 500 000 births.1 It was a descriptive term attributed to Meckel circa 1800. The key feature entails well-organised fetal structures in macroscopic pathology, with vertebral columns and, commonly, long bones of the limbs. Variable degree of organogenesis for the lung, liver, intestines, and genitalia has been commonly reported. Although grouped under the entity of teratoma and considered the well-differentiated end of the neoplastic spectrum in the current World Health Organization (WHO) classification,2 the true aetiology remains unclear. The theory of formation from monozygotic twins has been commonly implied in the literature.3 4 5
 
The commonest presentation of this condition was a painless mass lesion with or without pressure symptoms. Prenatal diagnosis was made in nine out of the 88 cases collectively reported by Hoeffel et al.3 We, hereby, report the case of a twin fetus-in-fetu presenting on antenatal ultrasound, and its histopathology.
 
Case report
Clinical course
A Chinese baby girl was admitted to our neonatal unit on the day of birth for antenatal diagnosis of a retroperitoneal mass in November 2010. This was a singleton pregnancy from natural conception, with allegedly normal antenatal ultrasound in early gestation. There were no additional morphology scans during second trimester ultrasound as the mother was a resident of mainland China where she received her obstetric care. Detailed antenatal ultrasound at 37 weeks of maturity showed a 32 mm x 30 mm x 30 mm mass in the left retroperitoneal region of the fetus. There were no other apparent abnormalities, or complicating intestinal or urinary obstruction. The initial differential diagnoses included congenital adrenal tumour and adrenal haemorrhage.
 
The birth weight of the baby was 4.07 kg. Physical examination showed fullness in the left flank. Targeted ultrasound of the retroperitoneal mass was performed immediately after birth. It showed cystic and solid components with areas of ossification within the mass which were suggestive of a teratoma. Abdominal X-ray showed neither dilated bowel nor calcification. Alpha fetoprotein and beta human chorionic gonadotropin levels measured on day 2 of life were normal for age. Clinically, the patient had no evidence of intestinal obstruction and tolerated full feeding soon after birth.
 
A detailed ultrasound of the abdominal region was performed on day 4 and computed tomography on day 7 (Fig 1). These showed a complex cystic mass between the spleen and the left kidney, with a maximal diameter of 47 mm. Within this single thin-walled cyst, there were two heterogeneous solid masses. Each mass contained a well-ossified spine and two ossified long bones at the caudal end, resembling the configuration of fetal femurs; no cardiac or cranial structures were identifiable.
 

Figure 1. Computed tomography showing the spine of each fetus (arrows)
 
To rule out the likelihood of neuroblastoma, urine catecholamine profile was performed which turned out to be normal. While imaging pointed to a likely fetus-in-fetu, the remote possibility of a mature teratoma could not be completely ruled out. Thus, a decision was made to perform an early excision of the mass.
 
Elective laparotomy was performed on day 14. Mobilisation of the colon at the splenic flexure revealed a retroperitoneal mass between the left kidney and left adrenal gland that was supplied by multiple, small feeding vessels from the aorta and left renal artery. After flush-dividing all investing vessels, the mass was resected with an intact capsule. The baby made good recovery from the operation and was discharged uneventfully on postoperative day 22.
 
Histopathology
Pathological section showed two fetiform masses, each with an umbilical cord connecting to a single placenta-like mass (Fig 2). The lengths of the fetuses were 37 mm and 35 mm, respectively. The larger mass contained better developed fetal structures and weighed 14.2 g, while the smaller mass weighed 9.3 g.
 

Figure 2. Fetuses-in-fetu with ‘umbilical cords’; (inset) mid-sagittal section of the fetus-in-fetu: ossified vertebra was seen containing bone marrow (dotted arrow), the spinal cord (white arrow), the non-patent anus (black arrow), and vacuolised intestines (striped arrows)
 
Within each of the ‘fetuses’, vacuolised intestines could be seen in the abdominal cavity but were leading to a non-patent anus (Fig 2, inset). Ambiguous external genitalia were identified in both fetuses. At the cranial end, there was no skull and no skin coverage. The rest of the fetus was covered by intact skin.
 
Regarding the skeletal formation, there was an ossified segmented spine in each fetus. The spinal cord was identified posterior to the vertebral bodies. A well-developed rib cage with bone and cartilage could be seen in the thoracic region. The pelvic bone and the long bones of the lower limbs were ossified with marrow formation in the centre. Two long bones could be identified in the forearm of the larger fetus. Metatarsals could be identified in both fetuses.
 
Microscopic examination revealed striated muscles, bones, and cartilages in the limbs. Ganglion cells were present in the spinal cord. The fetuses were covered by organised skin tissue and appendages. Respiratory mucosa was identified in the thoracic region. The intestines in the abdominal cavity were lined by intestinal mucosa. There was disorganised primitive brain tissue in the cranial end of both fetuses.
 
Discussion
Fetus-in-fetu is rare, with less than 200 cases reported in the literature. Hui et al6 reported, formally, the first regional case only in 2007. Despite the detailed description in literature, its aetiology and relationship with teratoma remains controversial.
 
Fetus-in-fetu is currently classified as a variant of mature teratoma. Previous case reports of recurrence after resection with malignant transformation also support this classification, whereby fetus-in-fetu should be the mature end of the spectrum of teratoma.7 However, the theory of monozygotic diamniotic twins has been increasingly proposed in the recent literature.3 8 Despite the gaining popularity, there is, as yet no concrete evidence to confirm this relationship. Blood group typing, karyotyping, and DNA analysis, when performed in the previously reported cases, always showed identical findings between the fetuses and their hosts. This finding is, however, compatible with both monozygotic multiple pregnancy theory and teratoma theory.
 
If we consider fetus-in-fetu a result of multiple pregnancy with initial normal embryological development, principles of embryological assessment may be considered. By diagnostic criteria, all fetuses-in-fetu possess vertebrae and, therefore, such an embryo should have reached the age of 24 to 25 days, corresponding to a gestational age of 5 weeks. In our case, and indeed in most other reported cases, the caudal neuropores were also closed. This further aged the estimated gestation to 6 weeks before the development was arrested in these presumed parasitic twins. In our case, since digital rays were clearly identified in the hands and feet, the embryonic age should be at least 44 to 46 days, which is 8 weeks by gestation.9 If we consider the abundant length of small bowel within the abdominal cavity, the gestational age had likely reached 10 weeks for both of these twin fetuses.
 
In conventional embryological assessment of aborted products of gestation, size of the fetus can sometimes be smaller than the normal size for embryological age, since the fetuses often undergo a certain period of growth restriction before the actual death. On the other hand, direct measurement of the specimen size may be slightly larger than the ultrasound assessment due to flattening of the tissue after its passage through the cervix.10 Interestingly, in the reported literature, a poor correlation has been observed between the level of organogenesis and size of the parasitic fetus. In a review of 87 cases by Hoeffel et al,3 there were 10 reported parasitic fetuses weighing over 500 g. The level of organogenesis in these fetuses, however, was immature compared to that of a normal 500 g fetus or newborn.3 If these parasitic fetuses were once products of multiple pregnancies, an interesting conclusion would be that these ‘fetuses’ continued to grow in size after their arrest in development or, theoretically, the ‘death’ of fetuses, although the ‘death’ of such fetuses is always difficult to define in view of their ‘acardiac’ nature.
 
With increasing application of assisted reproductive technology, a higher proportion of multiple pregnancies can now be monitored with ultrasound from early gestation. However, to date, there is no longitudinal observation of the evolution of fetus-in-fetu from multiple pregnancies, nor have there been any reported cases arising from assisted pregnancy. Whilst the earliest antenatal diagnosis of this condition in literature was 16 weeks’ gestation,11 no sequential monitoring of the antenatal history of fetus-in-fetu has been published.
 
In our case, both the twin parasitic fetuses had body weights, sizes, and fetal structures that corresponded well with a gestational age of 10 weeks. A normal ultrasound during the early antenatal period rather suggests that they might have been tiny parasitic fetuses that had grown slowly with the ‘patient’ and reached their significant sizes at term, instead of the popular theory of early normal development followed by parasitic inclusion and arrest of growth. Although with limited antenatal documentation, our case report does not support the popular monozygotic multiple pregnancy theory, and favours, by default, the traditional classification into a teratoma.
 
Conclusion
Less than 200 cases of twin fetus-in-fetu have been reported worldwide, and, to date, this was only the second regional case report. Although classified by WHO as a variant of mature teratoma, the theory of demised multiple pregnancy has gained much support recently. More evidence is needed to confirm either theory. The widespread use of antenatal ultrasound in early gestation may provide more concrete evidence from longitudinal observation and give light to the aetiology of this intriguing condition.
 
References
1. Grant R, Pearn JH. Foetus-in-foetu. Med J Aust 1969;1:1016-20.
2. Scully RE, Young RH, Clement PB. Atlas of tumor pathology, 3rd series, fascicle 23. Washington, DC: Armed Forces Institute of Pathology; 1998: ch13.
3. Hoeffel CC, Nguyen KQ, Phan HT, et al. Fetus in fetu: a case report and literature review. Pediatrics 2000;105:1335-44. CrossRef
4. Lewis RH. Foetus in foetu and retroperitoneal teratoma. Arch Dis Child 1961;36:220-6. CrossRef
5. Thrakral CL, Maji DC, Sajwani MJ. Fetus-in-fetu: a case report and review of the literature. J Pediatr Surg 1998;33:1432-4. CrossRef
6. Hui PW, Lam TP, Chan KL, Lee CP. Fetus in fetu—from prenatal ultrasound and MRI diagnosis to postnatal confirmation. Prenat Diagn 2007;27:657-61. CrossRef
7. Hopkins KL, Dickson PK, Ball TI, Ricketts RR, O’Shea PA, Abramowsky CR. Fetus-in-fetu with malignant recurrence. J Pediatr Surg 1997;32:1476-9. CrossRef
8. Mohan H, Chhabra S, Handa U. Fetus-in-fetu: a rare entity. Fetal Diagn Ther 2007;22:195-7. CrossRef
9. O’Rahilly R, Müller F. Developmental stages in human embryos. Carnegie Institute of Washington; 1987: Publication no. 637.
10. Harkness LN, Rodger M, Baird DT. Morphological and molecular characteristics of living human fetuses between Carnegie stages 7 and 23: ultrasound scanning and direct measurements. Hum Reprod Update 1996;3:25-33. CrossRef
11. Khatib MO, Deschamps F, Couture A, Giacalone PL, Boulot P. Early prenatal ultrasonographic diagnosis of fetus in fetu [in French]. J Gynecol Obstet Biol Reprod (Paris) 1998;27:438-40.
 
Find HKMJ in MEDLINE:
 

Synthetic fibre granuloma of the conjunctiva

DOI: 10.12809/hkmj144210
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
CASE REPORT
Synthetic fibre granuloma of the conjunctiva
ST Mak, FRCSEd (Ophth), FHKAM (Ophthalmology)1,2; YH Lui, FRCPA, FHKCPath3 #; Kenneth KW Li, FRCS (Ed), FHKAM (Ophthalmology)1,2
1 Department of Ophthalmology, United Christian Hospital, Kwun Tong, Hong Kong
2 Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong
3 Department of Pathology, United Christian Hospital, Kwun Tong, Hong Kong
# YH Lui is now with the Department of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong
 
Corresponding author: Dr ST Mak (dr.makst@gmail.com)
 
 Full paper in PDF
Abstract
Synthetic fibre granuloma of the conjunctiva, sometimes known as ‘teddy bear granuloma’, results from granulomatous foreign body reaction of the conjunctiva to synthetic fibres. It is often an incidental finding, most commonly found in children, is unilateral, and occurs in the lower eyelid. We present here, what we believe is the first reported case of synthetic fibre conjunctival granuloma in Hong Kong, together with a review of the condition. An awareness of this clinical entity allows early and accurate diagnosis and early treatment.
 
 
Introduction
Synthetic fibre granuloma of the conjunctiva, sometimes known as ‘teddy bear granuloma’, was first described by Weinberg et al in 1984.1 It is a rare granulomatous foreign body reaction of the conjunctiva to synthetic fibres. It occurs most commonly in children, and usually presents as a unilateral, inferior conjunctival mass of the lower eyelid. The lesion is known as ‘teddy bear granuloma’ because some cases were caused by materials used in stuffed toy animals.2
 
Seventeen cases of conjunctival synthetic fibre ‘teddy bear granuloma’ have been reported in the literature. To the best of our knowledge, this is the first reported case of this condition in Hong Kong.
 
Case report
A 7-year-old girl with good health presented to the ophthalmology clinic of United Christian Hospital, Hong Kong, in December 2012 with a left lower eyelid conjunctival mass for 1 month. There was no history of trauma. It was an incidental finding by the girl’s mother and the girl did not complain of any pain or discomfort. There was no change in visual acuity.
 
Examination showed a 3.5 mm x 1.5 mm conjunctival mass in the inferior fornix of her left lower eyelid (Fig a). It was embedded with a bunch of hair-like material. The lesion prolapsed easily with gentle pressure over the lower eyelid but could not be removed during slit-lamp examination. The rest of her ophthalmological examination was normal. The girl’s mother was very keen on removal of the mass. Excisional biopsy of the mass was performed under general anaesthesia. The mass was excised and sent for histopathological analysis.
 

Figure. (a) A slit-lamp photograph showing a conjunctival mass (arrows) in the inferior fornix of the left lower eyelid. Histopathological sections of the biopsy specimen: (b) conjunctival mucosal lesion contains numerous synthetic fibres in an inflamed background (H&E; original magnification, x 40); (c) synthetic fibres associated with foreign-body giant cell reaction are seen in an inflamed background (H&E; original magnification, x 100); (d) the synthetic fibres are refractile, colourless, and surrounded by histiocytic giant cells (H&E; original magnification, x 200)
 
Microscopic examination revealed a piece of conjunctival mucosa with stromal granulation tissue showing heavy chronic inflammation, mild activity, and aggregates of foreign body consistent with synthetic fibres, associated with giant cell reaction (Figs b to d). The fibres were refractile and colourless. In another section, scanty hair was seen in the stroma. The picture was compatible with a diagnosis of synthetic fibre granuloma of the conjunctiva.
 
Postoperatively, the wound healed well and there was no recurrence of the lesion at 1.5 years after excision.
 
Discussion
Protective mechanisms of the eye including blinking and tearing normally remove any foreign body that comes into contact with the ocular surface. Occasionally, foreign body may be retained in the eyelid fornix, encapsulated by mucous, embedded in the underlying stroma, and, subsequently, induces a local inflammatory response.2 Synthetic fibre granuloma of the conjunctiva occurs when synthetic fibres are inoculated in the conjunctiva of the eyelid fornix leading to an inflammatory reaction. The lesion is also commonly known as ‘teddy bear granuloma’ because some cases were caused by materials used in stuffed toy animals.2 Various other objects have been suggested as the source of the lesion, including blankets, beddings, and pullover sweaters.2 3 4
 
The majority of patients were brought in by parents or caretakers who identified a mass in the child’s eyelid. The patients were usually asymptomatic, without a history of trauma. Affected children may rarely present with symptoms of ocular irritation and foreign body sensation.5 Synthetic fibre conjunctival granuloma is usually unilateral, and mainly occurs in the inferior eyelid fornix, except in one reported case where it presented superiorly.1
 
Differential diagnoses of synthetic fibre conjunctival granuloma include chalazion, pyogenic granuloma, papillary hyperplasia, sarcoidosis, dermoid, or neoplasm including rhabdomyosarcoma.2 6 7 It has been proposed that the most reliable clinical sign to suggest this diagnosis was the presence of a unilateral inferior conjunctival mass in a child or adolescent.2 In addition, the histological features of synthetic fibre conjunctival granuloma are characteristic and diagnostic. Microscopic examination reveals granulomatous inflammatory cell response with lymphocytes, plasma cells and eosinophils, and foreign-body giant cells surrounding the exogenous synthetic fibres.4 8
 
Treatment of synthetic fibre conjunctival granuloma involves surgical removal of the foreign body and excision of the granuloma.2 Should the granuloma present early and the patient be compliant, it has been suggested to remove the lesion during slit-lamp examination under topical anaesthesia with minimal bleeding and discomfort.9 However, since the granuloma is usually present for a long duration before being noticed, the lesion could be deeply embedded. As a result, excision in the operating theatre under general anaesthesia is often needed, particularly when patients are very young and anxious. Prognosis following surgical excision is excellent.6
 
Although the entity of synthetic fibre conjunctival granuloma was recognised more than two decades ago, clinicians, including ophthalmologists and pathologists, are unfamiliar with this condition.4 While the number of reports in the literature is limited, accurate reporting may actually reveal a higher incidence of this entity.9 An awareness of this condition will allow early and accurate diagnosis and treatment, which subsequently spare the risks and expense associated with general anaesthesia.3
 
Declaration
No conflicts of interests were declared by authors.
 
References
1. Weinberg JC, Eagle RC Jr, Font RL, Streeten BW, Hidayat A, Morris DA. Conjunctival synthetic fiber granuloma. A lesion that resembles conjunctivitis nodosa. Ophthalmology 1984;91:867-72. CrossRef
2. Schmack I, Kang SJ, Grossniklaus HE, Lambert SR. Conjunctival granulomas caused by synthetic fibers: report of two cases and review of literature. J AAPOS 2005;9:567-71. CrossRef
3. Enzenauer RW, Speers WC. Teddy bear granuloma of the conjunctiva. J Pediatr Ophthalmol Strabismus 2002;39:46-8.
4. Ferry AP. Synthetic fiber granuloma. ‘Teddy bear’ granuloma of the conjunctiva. Arch Ophthalmol 1994;112:1339-41. CrossRef
5. Farooq MK, Prause JU, Heegaard S. Synthetic fiber from a teddy bear causing keratitis and conjunctival granuloma: case report. BMC Ophthalmol 2011;11:17. CrossRef
6. Shields JA, Augsburger JJ, Stechschulte J, Repka M. Synthetic fiber granuloma of the conjunctiva. Am J Ophthalmol 1985;99:598-600. CrossRef
7. Lueder GT. Synthetic fiber granuloma. Arch Ophthalmol 1995;113:848-9. CrossRef
8. Batta B, Robin A, George JL, Angioi K. “Teddy bear granuloma”, a rare condition: a case report of a 3-year-old child [in French]. J Fr Ophtalmol 2012;35:117-20. CrossRef
9. Resnick SC, Schainker BA, Ortiz JM. Conjunctival synthetic and nonsynthetic fiber granulomas. Cornea 1991;10:59-62. CrossRef
 
Find HKMJ in MEDLINE:
 

Magnetic resonance imaging features of vascular leiomyoma of the ankle

DOI: 10.12809/hkmj144259
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
CASE REPORT
Magnetic resonance imaging features of vascular leiomyoma of the ankle
Alta YT Lai, MB, BS, FRCR1; CW Tam, FRCR, FHKAM (Radiology)1; John SF Shum, FRCR, FHKAM (Radiology)2; Jennifer LS Khoo, FRCR, FHKAM (Radiology)1; WL Tang, FHKCPath, FHKAM (Pathology)3
1 Department of Radiology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong
2 Radiology Department, Hong Kong Baptist Hospital, Kowloon Tong, Hong Kong
3 Department of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong
 
Corresponding author: Dr Alta YT Lai (altalai@gmail.com)
 
 Full paper in PDF
Abstract
Vascular leiomyoma is a benign soft tissue tumour with a predilection for middle-aged women. It is most often seen in the extremities, particularly in the lower leg. The typical lesion is a small, slow-growing subcutaneous nodule. These tumours are often unexpected or preoperatively confused with other soft tissue tumours including low-grade sarcomas, leading to wide surgical excision. This may partly be due to the relatively few studies delineating the characteristic imaging features of this entity. Here, the imaging findings of a case of vascular leiomyoma in the ankle are presented. Literature review of the magnetic resonance imaging findings of published reports and series of vascular leiomyomas of the extremities is also performed.
 
 
Case report
A 47-year-old previously healthy Hong Kong Chinese man presented in January 2012 with a 2-year history of a slow-growing painless mass over the right medial malleolus. Physical examination showed a soft, well-marginated, non-tender mass measuring 2 cm in diameter over the right medial malleolus. The patient was referred for ultrasound and subsequently magnetic resonance imaging (MRI; Figs a to i). The lesion was excised. Macroscopically, it was a disc-shaped mass with smooth outer surface. Cut section showed a mass with a thin capsule and homogeneous, greyish-to-whitish material without necrosis. Microscopy showed proliferation of smooth muscle cells associated with thick-walled blood vessels without evidence of malignancy. The histopathological diagnosis was vascular leiomyoma (Figs j and k).
 

Figure. A 47-year-old man with a 2-year history of a slow-growing, painless, soft ankle mass
(a) Grey-scale ultrasound and (b) power Doppler study demonstrate a well-circumscribed, mildly compressible, mildly echogenic, subcutaneous lesion adjacent to the right medial malleolus with intralesional slow-flow vessels. No feeding artery, dilated draining vein, or phlebolith is found. Overall features are suggestive of a mildly vascular solid mass. (c, g) It is well-circumscribed and markedly hyperintense with a peripheral hypointense rim (arrows) on axial and coronal T2-weighted images. (d) No susceptibility artefacts are observed in the lesion on gradient echo sequence image, suggesting the absence of intralesional haemorrhage. (e, h) It is slightly hyperintense to muscle on T1-weighted images, with (f, i) homogeneous enhancement upon intravenous administration of gadolinium. The underlying bone, subjacent flexor retinaculum (arrowhead) and medial ankle tendons (arrows) were intact. (j, k) Microscopic pictures of the tumour section include central blood vessels (arrows) surrounded by peripheral smooth muscle. The histopathological diagnosis is vascular leiomyoma (H&E, original magnification: [j] x 5 and [k] x 100)
 
Discussion
Vascular leiomyoma, angiomyoma or angioleiomyoma, is a rare benign smooth muscle tumour that originates in the tunica media of veins and arteries. It can be located in the skin, subcutaneous fat, or superficial fasciae of the extremities. It has a predilection for middle-aged women. It can occur anywhere in the body, but is most often seen in the extremities, particularly in the lower leg.1
 
The most frequent clinical presentation is a mass that enlarges slowly over several years. The size usually ranges from subcentimetre to a few centimetres in diameter, but occasionally may grow larger. They are usually oval or round in shape, and can be located in the skin, subcutaneous fat, or the superficial fasciae of the extremities.
 
Pain, with or without tenderness, has been reported in about 60% of patients, and is thought to be caused by the active contraction of smooth muscles resulting in local ischaemia, and is also suggested to be mediated by intratumoural nerve fibres.2 Treatment usually consists of marginal excision.2
 
Angioleiomyomas are rarely diagnosed preoperatively. In a series of 10 cases by Gupte et al1 in 2008, the preoperative or pre-biopsy imaging diagnoses included sarcoma not otherwise specified, schwannoma, myositis ossificans, synovial sarcoma, and fibroma. This may be partly due to the relatively few studies delineating the characteristic imaging features of this entity. The preoperative differentiation of angioleiomyoma from other soft tissue tumours is of clinical importance, especially sarcomas, since angioleiomyomas are benign and can be treated with simple excision. Literature review of the MRI findings of currently published reports and series of vascular leiomyomas of the extremities is presented below.
 
Literature review
Materials, methods, and patient demographics
A PubMed search of the English literature was performed, using the key words “vascular leiomyoma”, “angioleiomyoma”, and “angiomyoma”. From 1998 to 2011, 36 cases of biopsy-proven vascular leiomyomas in the extremities of adults with detailed descriptions of T1-weighted images (T1WI) and T2-weighted images (T2WI) were found. Articles without detailed descriptions or figures of T1WI and T2WI were excluded. Not all studies in the literature may have been included in this review because of unavailability in PubMed or in English language. After including our case, this review has 37 cases. The mean age of the patients was 51 years (range, 20-72 years). There were 16 male and 17 female patients; the gender of the remaining four patients was not stated.
 
Results
Among the 26 lesions with documented sizes, the mean size of the lesions was 3.2 cm (range, 0.4-12 cm). Overall, 40.5% (15/37) of the lesions were in the upper limb and 59.5% (22/37) were in the lower limb. All of them were located in the subcutaneous layer, were well-defined, and round, oval or disc-shaped. On T1WI, 91.9% (34/37) of the tumours showed isointense–to–slightly high signal intensity, 5.4% were heterogeneous, and 2.7% showed low signal intensity. On T2WI, all the cases demonstrated high signal intensity. Signal voids were seen in 10.8% (4/37) of the tumours, either on T1WI or T2WI. Among the 33 cases in which contrast was administered, only two (6.1%) cases showed no or poor enhancement, 93.9% (31/33) showed enhancement, 42.4% (14/33) were homogeneous, and 39.4% (13/33) were described as showing heterogeneous enhancement. One case showed peripheral enhancement, one showed central enhancement. One case showed rapid enhancement and one case demonstrated slow enhancement. Among the cases in which the presence or absence of peripheral hypointense rim was recorded, a hypointense rim was found on T2WI in 85.2% of cases (23/27; Table1 2 3 4 5 6 7 8 9 10 11 12 13 14).
 

Table. Magnetic resonance imaging findings in 37 patients with vascular leiomyomas in extremities1 2 3 4 5 6 7 8 9 10 11 12 13 14
 
Vascular leiomyomas often show similar signal intensity to that of muscle on T1WI. A T2WI is expected to demonstrate mixed areas that are hyper- and isointense to muscle. A well-defined peripheral T2-hypointense rim may be seen, representing the fibrous capsule. It has been reported that T2-hyperintense areas correlated with strong contrast enhancement, whereas isointense areas did not show enhancement after intravenous administration of contrast material.3 It was suggested that the smooth muscle and numerous vessels corresponded to the hyperintense areas, and the fibrous tissue appeared isointense on T2WI. Tortuous vascular structures with signal void may also be seen.
 
Imaging differentials
The differentials of a well-defined, enhancing, subcutaneous nodule or mass with T2-hyperintense signals include synovial sarcoma, other low-grade soft tissue sarcomas, haemangioma, neurogenic tumour, and nodular fasciitis.
 
Low-grade sarcomas such as synovial sarcoma and low-grade myxofibrosarcoma may be slow-growing and appear well-circumscribed on MRI, giving the misleading impression that the lesion is well-localised. Haemorrhage may be present in synovial sarcomas, which may be seen as fluid-fluid levels, T2 hypointensity, or “triple signal intensity”, namely areas of hyperintensity, isointensity and hypointensity relative to fat, due to presence of cystic, solid and fibrous elements with haemorrhage. It is unknown whether the absence of haemorrhage, a more homogeneous appearance, and the presence of a peripheral hypointense rim are reliable distinguishing features favouring angioleiomyoma over otherwise benign-appearing, soft tissue sarcomas; this may be a potential knowledge gap that future prospective comparison studies may serve to fill.
 
Haemangiomas may show homogeneous signals if these are small, making it challenging to differentiate from angioleiomyomas. Phleboliths can be sought for on plain radiographs. Fatty and serpentine vascular elements may be identified in haemangiomas, which are pathognomonic. The classical ‘target’ sign, ‘split-fat’ sign, and fusiform tumour shape demonstrated in neurogenic tumours are not found in angioleiomyomas. Although nodular fasciitis demonstrates similar shape and size as angioleiomyomas, linear extension along the fascia, surrounding oedema, low T1 signal, heterogeneous T2 signal, and non-homogeneous enhancement are features that differ from characteristic imaging features of angioleiomyoma.15
 
On microscopic examination, the presence of tortuous vascular channels surrounded by smooth muscle bundles and areas of myxoid change may be seen. This explains the heterogeneity of signal intensity in the tumour on T2WI. Magnetic resonance imaging–histopathological correlation published by Hwang et al2 stated that the smooth muscle and numerous vessels within each type of vascular leiomyoma corresponded with the hyperintense areas on T2WI, and the tough fibrous tissue appeared isointense on T2WI. In addition, a well-defined peripheral hypointense area on T2WI correlated with the fibrous capsule, and the interlacing isointense areas within the tumour correlated with the various quantity of connective tissue and intravascular thrombus.3
 
Conclusions
Vascular leiomyoma should be considered a possible diagnosis when a well-demarcated oval or round subcutaneous mass with T1-isointense–to–slightly high signal, T2-high signal intensity, hypointense rim, and intense enhancement is seen in the soft tissue of the extremities. It is unknown whether the absence of haemorrhage, a more homogeneous appearance, and the presence of a peripheral hypointense rim are reliable distinguishing features favouring angioleiomyoma over otherwise benign-appearing soft tissue sarcomas; this may be a potential knowledge gap that future prospective comparison studies may serve to fill.
 
References
1. Gupte C, Butt SH, Tirabosco R, Saifuddin A. Angioleiomyoma: magnetic resonance imaging features in ten cases. Skeletal Radiol 2008;37:1003-9. CrossRef
2. Hwang JW, Ahn JM, Kang HS, Suh JS, Kim SM, Seo JW. Vascular leiomyoma of an extremity: MR imaging–pathology correlation. AJR Am J Roentgenol 1998;171:981-5. CrossRef
3. Yoo HJ, Choi JA, Chung JH, et al. Angioleiomyoma in soft tissue of extremities: MRI findings. AJR Am J Roentgenol 2009;192:W291-4. CrossRef
4. Kinoshita T, Ishii K, Abe Y, Naganuma H. Angiomyoma of the lower extremity: MR findings. Skeletal Radiol 1997;26:443-5. CrossRef
5. Turhan-Haktanir N, Haktanir A, Demir Y, Tokyol C, Acar M. Toe leiomyoma: A case report with radiological correlation. Acta Chir Belg 2006;106:92-5.
6. Nagata S, Nishimura H, Uchida M, Hayabuchi N, Zenmyou M, Fukahori S. Giant angioleiomyoma in extremity: report of two cases. Magn Reson Med Sci 2006;5:113-8. CrossRef
7. Hamoui M, Largey A, Ali M, et al. Angioleiomyoma in the ankle mimicking tarsal tunnel syndrome: a case report and review of the literature. J Foot Ankle Surg 2010;49:398.e9-15.
8. Shafi M, Hattori Y, Doi K. Angioleiomyoma of distal ulnar artery of the hand. Hand (N Y) 2010;5:82-5. CrossRef
9. Gulati MS, Kapoor A, Maheshwari J. Angiomyoma of the knee joint: value of magnetic resonance imaging. Australas Radiol 1999;43:353-4. CrossRef
10. Kugimoto Y, Asami A, Shigematsu M, Hotokebuchi T. Giant vascular leiomyoma with extensive calcification in the forearm. J Orthop Sci 2004;9:310-3. CrossRef
11. Waldt S, Rechl H, Rummeny EJ, Woertler K. Imaging of benign and malignant soft tissue masses of the foot. Eur Radiol 2003;13:1125-36.
12. Sookur PA, Saifuddin A. Indeterminate soft-tissue tumors of the hand and wrist: a review based on a clinical series of 39 cases. Skeletal Radiol 2011;40:977-89. CrossRef
13. Okahashi K, Sugimoto K, Iwai M, Oshima M, Takakura Y. Intra-articular angioleiomyoma of the knee: a case report. Knee 2006;13:330-2. CrossRef
14. Stock H, Perino G, Athanasian E, Adler R. Leiomyoma of the foot: sonographic features with pathologic correlation. HSS J 2011;7:94-8. CrossRef
15. Walker EA, Fenton ME, Salesky JS, Murphey MD. Magnetic resonance imaging of benign soft tissue neoplasms in adults. Radiol Clin North Am 2011;49:1197-217. CrossRef
 
Find HKMJ in MEDLINE:
 

Xanthogranulomatous inflammation of terminal ileum: report of a case with small bowel involvement

DOI: 10.12809/hkmj134103
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
CASE REPORT
Xanthogranulomatous inflammation of terminal ileum: report of a case with small bowel involvement
KC Wong, MCSHK, MRCSEd1; Wilson MS Tsui, FIAC, FRCPath2; SJ Chang, FRCS, FRCSEd1
1 Department of Surgery, Caritas Medical Centre, Shamshuipo, Hong Kong
2 Department of Pathology, Caritas Medical Centre, Shamshuipo, Hong Kong
 
Corresponding author: Dr KC Wong(kamkam44@gmail.com)
 
 Full paper in PDF
Abstract
Xanthogranulomatous inflammation is a rare pathological condition most frequently detected in the kidney and gallbladder. Reported herein is a case of xanthogranulomatous inflammation in a 51-year-old male presenting as a mass-forming lesion in the terminal ileum with mucosal ulceration. Diagnostic laparoscopy followed by ileocecectomy was performed due to intra-operative suspicion of carcinoma of appendix. This is a report of the condition involving the terminal ileum with mucosal ulceration and full-thickness involvement of bowel wall which are uncommon features of xanthogranulomatous inflammation in previously reported lower gastro-intestinal tract lesions.
 
 
Introduction
Xanthogranulomatous inflammation (XGI) is a rare but well-defined disease, first reported by Oberling in 1935.1 The disease process was most frequently reported in the kidney and gallbladder. Rare occurrence in the gastro-intestinal tract was illustrated in only one recently reported case in the terminal ileum,2 four reported cases in the colon,3 4 5 6 eight cases in a series of interval appendicectomy specimens,7 and eight cases with gastric involvement.8 9 10 11 12 13 Of the four cases with colonic involvement, two involved the sigmoid colon,3 4 one involved the caecum,5 and one involved the ascending colon.6 Most of these colonic lesions presented with a mass-forming lesion with predominant submucosal involvement, while primary mucosal involvement was only reported in the last case involving the ascending colon. We, herein, report the second case of XGI in the terminal ileum with mucosal ulceration and full-thickness involvement of the bowel wall, presenting as a painful right-lower-quadrant abdominal mass.
 
Case report
A 51-year-old Chinese male presented to the Emergency Department on 2 December 2012. He was a chronic smoker and alcoholic. He complained of right-sided abdominal pain for the past 2 weeks. The pain was not associated with nausea, vomiting, constipation, or diarrhoea. There was no anorexia or weight loss. There was no history of melaena. His medical history included diabetes, hypertension, and gout. There was no history of tuberculosis.
 
He was admitted to a hospital in Mainland China 10 days before the index admission for the same problem. While in that hospital, he had raised white cell count of 16.2 x 109 /L, and an ultrasound of abdomen revealed a gallstone and a renal stone. There was no hydronephrosis. A course of antibiotics was given, but the symptoms persisted. The patient returned from Mainland China on 2 December 2012, and attended our Emergency Department for further management.
 
On admission, the physical examination of the respiratory, cardiovascular, and central nervous systems was unremarkable. Abdominal examination revealed tenderness in the right lower quadrant. Per rectal examination revealed no blood, melaena, or mass. Abdominal X-ray showed no specific abnormalities.
 
His blood tests revealed mildly elevated white cell count of 10.6 x 109 /L (reference range [RR], 3.7-9.2 x 109 /L), haemoglobin level of 137 g/L (RR, 134-171 g/L), normal amylase level of 57 U/L (RR, 30-128 U/L), and normal electrolytes and liver enzymes. An urgent ultrasound of the abdomen and pelvis raised suspicion of acute appendicitis, with a tubular, non-peristaltic, non-compressible structure measuring 1.55 cm in diameter at the appendicular region, with small amount of loculated fluid around the lesion (Fig 1), corresponding with the site of maximum tenderness. The distal end of the lesion was obscured by bowel gas; it could not be ascertained whether it was blind-ended. The same study also revealed the presence of a gallstone and a right lower pole renal stone.
 

Figure 1. An ultrasound image of the right-lower-quadrant mass showing a tubular, non-peristaltic, non-compressible structure in the appendicular region with small amount of loculated free fluid (arrow) around the lesion. The distal end of the lesion is obscured by bowel gas; it could not be ascertained whether it was blind-ended
 
With a preliminary diagnosis of acute appendicitis, diagnostic laparoscopy was performed on 3 December 2012. There was an ileocaecal mass fixed to the posterior abdominal wall, which was difficult to mobilise despite an open approach via gridiron incision. Upon conversion to midline laparotomy, a large inflammatory mass was found at the ileocaecal junction, compatible with an infiltrative tumour. The mass demonstrated through-and-through invasion into the ileal mesentery, involving several loops of the ileum. Ileocaecal lymph node enlargement was noted. The appendix was not identified. There was no gross cavity or pus. With the suspicion of carcinoma of appendix, limited right hemicolectomy with en-bloc resection of the mass together with 65 cm of the terminal ileum, caecum, and proximal ascending colon was performed. Primary sub-end to sub-end, side-to-side anastomosis was fashioned.
 
The postoperative course of the patient was complicated by on-and-off fever with elevated white cell count of up to 22.5 x 109 /L. Blood culture taken on postoperative day 2 yielded no bacterial growth. Erythema and serous discharge were noted in the paraumbilical region of the laparotomy and gridiron wounds, which were managed with dressing and packing. Wound swab yielded scanty growth of Escherichia coli. The fever responded to a 10-day course of cefuroxime and metronidazole. He was discharged on postoperative day 10.
 
A colonoscopy done 4 months after the operation in April 2013 revealed no abnormalities.
 
Pathological examination
Gross examination of the ileocolectomy specimen revealed a 0.5-cm ileal mucosal ulcer, which was 1.5 cm proximal to the ileocaecal valve. The periappendicular mass was haemorrhagic and covered with exudate, within which was a retrocaecal appendix, measuring 5 cm in length and 1 cm in diameter, surrounded by necrotic and yellowish tissue. Cut surface of the appendix was unremarkable. A few lymph nodes were found in the ileocaecal fossa.
 
Microscopic examination of the appendicular mass showed abscess, haemorrhage, and XGI which consisted predominantly of foamy histiocytes, scattered neutrophils, lymphoplasmacytic cells, a few multinucleated giant cells, and congested capillaries with surrounding fibrosis (Fig 2). The foamy histiocytes were positive for CD68 on immunostaining, confirming their histiocytic origin. No Michaelis-Gutmann bodies were detected. The terminal ileum ulcer revealed similar XGI which extended through the bowel wall to involve the mesentery. The appendicular mucosa showed no neutrophilic infiltrate. A few reactive lymph nodes were noted. There was no evidence of malignancy or granuloma.
 

Figure 2. Microscopic examination of the appendicular mass. (a) Terminal ileum featuring ulceration (arrow) and underlying inflammation (H&E; original magnification, x 10). (b) Appendix buried in the inflammatory mass but showing intact muscle wall and non-inflamed mucosa (H&E; original magnification, x 10). (c) Xanthogranulomatous inflammation comprising mainly foamy histiocytes (arrows), scattered neutrophils, a few lymphoid cells, and congested capillaries (H&E; original magnification, x 100). (d) High-power view to reveal the lipid-laden foamy histiocytes (arrows) [H&E; original magnification, x 400]
 
Discussion
Xanthogranulomatous inflammation is a form of chronic inflammatory condition characterised macroscopically by mass-forming golden yellow tumours and microscopically by aggregation of lipid-laden foamy histiocytes including multinucleated giant cells, with a minor component of chronic and acute inflammatory cells and fibrous reaction. It was first described by Oberling in 1935 in three cases of retroperitoneal xanthogranulomas.1 Its occurrence in the endometrium, ovary, fallopian tubes, vagina, testis, epididymis, stomach, bone, skin (as fistulation secondary to inflammation primarily involving another internal organ),14 appendix,7 15 urinary bladder, thyroid, and adrenal glands has been reported, with the highest prevalence reported in the kidney and gallbladder. A majority of XGI cases present as a mass-like lesion with an extension of fibrosis and inflammation to the surrounding tissues, leading to diagnostic difficulties in differentiating them from infiltrative malignant tumours.
 
Pathological differential diagnoses bearing similar histological features include malakoplakia, which is characterised by an inflammatory and destructive xanthomatous proliferation with the presence of Michaelis-Gutmann bodies, which are intracytoplasmic laminated concretions usually positive for periodic acid–Schiff, von Kossa, and Prussian blue stains. Macrophages known as von Hansemann cells are more granular and eosinophilic and have less vacuolated cytoplasm than ordinary histocytes. Other differential diagnoses include localised xanthoma deposits without parenchymal destruction or xanthomas with prominent foam cell features.
 
Although the pathological features of XGI are well described, its exact pathogenesis is not well established.
 
Various proposed mechanisms include chronic recurrent infection, obstruction, immunological disorders, and defective lipid transport. It is generally believed that the localised proliferation of lipid-laden foamy histiocytes in XGI represents chronic suppurative inflammation secondary to interaction between the host and micro-organisms. Examples of immunological disorders include disrupted chemotaxis of polymorphs and macrophages, which is a specific immune response toward Proteus and Escherichia infections. A recently reported case2 involving the terminal ileum proposed a possible mechanism of perforation due to an ingested foreign body. However, none of the above hypotheses were able to fully explain the anatomical distribution of the condition, which is most common in the appendix where neither perforation due to ingested foreign bodies nor chronic suppurative inflammation is most often found. In this reported case, infected laparotomy wound swab yielded E coli, while there were no symptoms to suggest pre-existing chronic suppurative inflammation. There was no evidence of a penetrating foreign body on history or gross examination of the pathological specimen.
 
Rare occurrence of XGI in the lower gastro-intestinal tract is illustrated by only one reported case in the terminal ileum,2 four reported cases in the colon with two involving the sigmoid colon,3 4 one involving the caecum,5 and one involving the ascending colon.6 However, a histopathological review of 22 interval appendicectomy specimens by Guo and Greenson7 in 2003 reported presence of XGI in eight cases (36.4%) of interval appendicectomy versus none in the 44 matched patients receiving acute appendicectomy, suggesting XGI may be underreported as a delayed consequence of acute inflammation and that these histological changes are secondary to the time interval of inflammation rather than intrinsic factors specific to the patient or disease.
 
Due to endoscopic, radiological, and the intra-operative macroscopic resemblance to infiltrative malignant neoplasms, these lesions warrant excision with a wide margin, similar to treatment of locally advanced malignancies.
 
However, there has been inadequate evidence to suggest association between XGI and gastro-intestinal malignancies. Of the eight cases of XGI of the stomach reported in the literature,8 9 10 11 12 13 co-existence of XGI with gastric cancer was reported in three cases. Histological examination of these cases did not support continuity between the xanthogranuloma and adenocarcinoma. In the other case of XGI in the terminal ileum reported by Yoon et al,2 preoperative endoscopy and biopsy showed ulcers with acute and chronic inflammation only. However, surgical resection was considered unavoidable in view of the radiological findings highly suggestive of appendiceal cancer. While preoperative endoscopic biopsy may not be helpful to exclude malignancy as most of the lesions are submucosal, intra-operative frozen section may be helpful to avoid unnecessary radical surgery.
 
Conclusion
We report a case of XGI with full-thickness involvement of the terminal ileum presenting with a tender intraperitoneal mass. This report aimed to emphasise ileal involvement of XGI, although rare, as one of the differential diagnoses of mass lesions in the small bowel mimicking malignant neoplasms.
 
Declaration
No conflicts of interest were declared by the authors.
 
References
1. Oberling C. Retroperitoneal xanthogranuloma. Am J Cancer 1935;23:477-89. CrossRef
2. Yoon JS, Jeon YC, Kim TY, et al. Xanthogranulomatous inflammation in terminal ileum presenting as an appendiceal mass: case report and review of the literature. Clin Endosc 2013;46:193-6. CrossRef
3. Lo CY, Lorentz TG, Poon CS. Xanthogranulomatous inflammation of the sigmoid colon: a case report. Aust N Z J Surg 1996;66:643-4. CrossRef
4. Oh YH, Seong SS, Jang KS, et al. Xanthogranulomatous inflammation presenting as a submucosal mass of the sigmoid colon. Pathol Int 2005;55:440-4. CrossRef
5. Anadol AZ, Gonul II, Tezel E. Xanthogranulomatous inflammation of the colon: a rare cause of cecal mass with bleeding. South Med J 2009;102:196-9.
6. Dhawan S, Jain D, Kalhan SK. Xanthogranulomatous inflammation of ascending colon with mucosal involvement: report of a first case. J Crohns Colitis 2011;5:245-8. CrossRef
7. Guo G, Greenson JK. Histopathology of interval (delayed) appendectomy specimens: strong association with granulomatous and xanthogranulomatous appendicitis. Am J Surg Pathol 2003;27:1147-51. CrossRef
8. Zhang L, Huang X, Li J. Xanthogranuloma of the stomach: a case report. Eur J Surg Oncol 1992;18:293-5.
9. Guarino M, Reale D, Micoli G, Tricomi P, Cristofori E. Xanthogranulomatous gastritis: association with xanthogranulomatous cholecystitis. J Clin Pathol 1993;46:88-90. CrossRef
10. Lespi PJ. Gastric xanthogranuloma (inflammatory malignant fibrohistiocytoma). Case report and literature review [in Spanish]. Acta Gastroenterol Latinoam 1998;28:309-10.
11. Lai HY, Chen JH, Chen CK, et al. Xanthogranulomatous pseudotumor of stomach induced by perforated peptic ulcer mimicking a stromal tumor. Eur Radiol 2006;16:2371-2. CrossRef
12. Kubosawa H, Yano K, Oda K, et al. Xanthogranulomatous gastritis with pseudosarcomatous changes. Pathol Int 2007;57:291-5. CrossRef
13. Kinoshita H, Yamaguchi S, Sakata Y, Arii K, Mori K, Kodama R. A rare case of xanthogranuloma of the stomach masquerading as an advanced stage tumor. World J Surg Oncol 2011;9:67. CrossRef
14. Rogers S, Slater DN, Anderson JA, Parsons MA. Cutaneous xanthogranulomatous inflammation: a potential indicator of internal disease. Br J Dermatol 1992;126:290-3.
15. Chuang YF, Cheng TI, Soong TC, Tsou MH. Xanthogranulomatous appendicitis. J Formos Med Assoc 2005;104:752-4. CrossRef
 
Find HKMJ in MEDLINE:
 

Pages